Lam Research (LRCX) 10-Q 25 Oct 16 2017 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Sep. 25, 2016	Oct. 20, 2016
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 25, 2016
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q1
Trading Symbol	LRCX
Entity Registrant Name	LAM RESEARCH CORP
Entity Central Index Key	707,549
Current Fiscal Year End Date	--06-25
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		162,829,959

Condensed Consolidated Statemen

Condensed Consolidated Statements Of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Sep. 25, 2016	Sep. 27, 2015
Income Statement [Abstract]
Revenue	$ 1,632,419	$ 1,600,043
Cost of goods sold	916,222	877,680
Gross margin	716,197	722,363
Research and development	235,240	234,209
Selling, general and administrative	165,010	152,726
Total operating expenses	400,250	386,935
Operating income	315,947	335,428
Other expense, net	(23,154)	(27,121)
Income before income taxes	292,793	308,307
Income tax expense	(28,958)	(19,628)
Net income	$ 263,835	$ 288,679
Net income per share:
Basic (in dollars per share)	$ 1.64	$ 1.82
Diluted (in dollars per share)	$ 1.47	$ 1.66
Number of shares used in per share calculations:
Basic (in shares)	160,607	158,352
Diluted (in shares)	180,017	174,374
Cash dividend declared per common share (in dollars per share)	$ 0.30	$ 0.30

Condensed Consolidated Stateme3

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended
	Sep. 25, 2016	Sep. 27, 2015
Statement of Comprehensive Income [Abstract]
Net income	$ 263,835	$ 288,679
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustment	4,501	(7,822)
Cash flow hedges:
Net unrealized losses during the period	(2,421)	(544)
Net losses reclassified into earnings	11,950	341
Net change	9,529	(203)
Available-for-sale investments:
Net unrealized (losses) gains during the period	(2,723)	2,748
Net losses reclassified into earnings	903	20
Net change	(1,820)	2,768
Defined benefit plans, net change in unrealized component	123	95
Other comprehensive loss, net of tax	12,333	(5,162)
Comprehensive income	$ 276,168	$ 283,517

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 25, 2016	Jun. 26, 2016	[1]
ASSETS
Cash and cash equivalents	$ 5,861,701	$ 5,039,322
Investments	1,352,775	1,788,612
Accounts receivable, less allowance for doubtful accounts of $7,124 as of September 25, 2016 and $5,155 as of June 26, 2016	1,290,317	1,262,145
Inventories	931,581	971,911
Prepaid expenses and other current assets	162,628	151,160
Total current assets	9,599,002	9,213,150
Property and equipment, net	649,587	639,608
Restricted cash and investments	255,640	250,421
Goodwill	1,385,838	1,386,276
Intangible assets, net	526,593	564,921
Other assets	219,702	209,939
Total assets	12,636,362	12,264,315
LIABILITIES AND STOCKHOLDERS’ EQUITY
Trade accounts payable	349,743	348,199
Accrued expenses and other current liabilities	765,655	772,910
Deferred profit	417,855	349,199
Current portion of convertible notes and capital leases	952,999	947,733
Total current liabilities	2,486,252	2,418,041
Senior notes, convertible notes, and capital leases, less current portion	3,378,179	3,378,129
Income taxes payable	241,671	231,514
Other long-term liabilities	142,910	134,562
Total liabilities	6,249,012	6,162,246
Commitments and contingencies
Temporary equity, convertible notes	202,467	207,552
Stockholders’ equity:
Preferred stock, at par value of $0.001 per share; authorized - 5,000 shares, none outstanding	0	0
Common stock, at par value of $0.001 per share; authorized, 400,000 shares; issued and outstanding, 161,706 shares at September 25, 2016 and 160,201 shares at June 26, 2016	162	160
Additional paid-in capital	5,627,839	5,572,898
Treasury stock, at cost, 100,767 shares at September 25, 2016 and 101,071 shares at June 26, 2016	(4,421,665)	(4,429,317)
Accumulated other comprehensive loss	(57,000)	(69,333)
Retained earnings	5,035,547	4,820,109
Total stockholders’ equity	6,184,883	5,894,517
Total liabilities and stockholders’ equity	$ 12,636,362	$ 12,264,315
[1]	Derived from audited financial statements

Condensed Consolidated Balance5

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Sep. 25, 2016	Jun. 26, 2016
Statement of Financial Position [Abstract]
Accounts receivable, allowance for doubtful accounts	$ 7,124	$ 5,155
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	400,000,000	400,000,000
Common stock, shares issued	161,706,000	160,201,000
Common stock, shares outstanding	161,706,000	160,201,000
Treasury stock, shares	100,767,000	101,071,000

Condensed Consolidated Stateme6

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Sep. 25, 2016		Sep. 27, 2015
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 263,835		$ 288,679
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	74,562		70,590
Deferred income taxes	7,633		(5,563)
Equity-based compensation expense	38,595		35,774
Income tax benefit on equity-based compensation plans	0		3,545
Excess tax benefit on equity-based compensation plans	0		(3,572)
Amortization of note discounts and issuance costs	6,830		9,831
Other, net	16,807		10,011
Changes in operating assets and liabilities	64,962		39,702
Net cash provided by operating activities	473,224		448,997
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures and intangible assets	(41,979)		(49,454)
Purchases of available-for-sale securities	(38,149)		(358,854)
Sales and maturities of available-for-sale securities	469,899		330,651
Transfer of restricted cash and investments	(5,219)		0
Other, net	(7,800)		(1,500)
Net cash provided by (used for) investing activities	376,752		(79,157)
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments on long-term debt and capital lease obligations and payments for debt issuance costs	(371)		(96)
Proceeds from issuance of long-term debt, net of issuance costs	0		0
Excess tax benefit on equity-based compensation plans	0		3,572
Treasury stock purchases	(1,854)		(98,385)
Dividends paid	(48,052)		(47,659)
Reissuance of treasury stock related to employee stock purchase plan	19,320		19,245
Proceeds from issuance of common stock	1,459		377
Other, net	(10)		(300)
Net cash (used for) provided by financing activities	(29,508)		(123,246)
Effect of exchange rate changes on cash and cash equivalents	1,911		(3,808)
Net increase in cash and cash equivalents	822,379		242,786
Cash and cash equivalents at beginning of period	5,039,322	[1]	1,501,539
Cash and cash equivalents at end of period	5,861,701		1,744,325
Schedule of noncash transactions:
Accrued payables for stock repurchases	0		7,624
Accrued payables for capital expenditures	11,631		6,761
Dividends payable	48,397		47,896
Transfers of inventory to (from) property and equipment, net	$ 13,419		$ (779)
[1]	Derived from audited financial statements

BASIS OF PRESENTATION

BASIS OF PRESENTATION	3 Months Ended
	Sep. 25, 2016
Accounting Policies [Abstract]
BASIS OF PRESENTATION	BASIS OF PRESENTATION The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and the instructions to Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation have been included. The accompanying unaudited Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements of Lam Research Corporation (“Lam Research” or the “Company”) for the fiscal year ended June 26, 2016 , which are included in the Company’s Annual Report on Form 10-K as of and for the year ended June 26, 2016 (the “2016 Form 10-K”). The Company’s reports on Form 10-K, Form 10-Q and Form 8-K are available online at the Securities and Exchange Commission website on the Internet. The address of that site is www.sec.gov . The Company also posts its reports on Form 10-K, Form 10-Q and Form 8-K on its corporate website at http://investor.lamresearch.com . The content on any website referred to in this Form 10-Q is not a part of or incorporated by reference in this Form 10-Q unless expressly noted. The condensed consolidated financial statements include the accounts of Lam Research and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. The Company’s reporting period is a 52/53-week fiscal year. The Company’s current fiscal year will end June 25, 2017 and includes 52 weeks. The quarters ended September 25, 2016 (the “September 2016 quarter”) and September 27, 2015 (the “September 2015 quarter”) included 13 weeks.

RECENT ACCOUNTING PRONOUNCEMENT

RECENT ACCOUNTING PRONOUNCEMENTS	3 Months Ended
	Sep. 25, 2016
Accounting Changes and Error Corrections [Abstract]
RECENT ACCOUNTING PRONOUNCEMENTS	RECENT ACCOUNTING PRONOUNCEMENTS In May 2014, the FASB released Accounting Standards Update (“ASU”) 2014-9, “Revenue from Contracts with Customers” to supersede nearly all existing revenue recognition guidance under GAAP. The core principle of the standard is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration that is expected to be received for those goods or services. The new standard defines a five step process to achieve this core principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing GAAP, including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. In April 2016, FASB released ASU 2016-10, "Revenue from Contracts with Customers." The amendment clarifies guidance in ASU 2014-09, “Revenue from Contracts with Customers” to improve guidance on criteria in assessing whether promises to transfer goods and services are separately identifiable and improve the understanding of the licensing implementation guidance. In May 2016, FASB released ASU 2016-12, "Revenue from Contracts with Customers." which also clarifies guidance in ASU 2014-09 on assessing collectability, non-cash consideration, presentation of sales tax and completed contracts and contract modification in transition. The Company is required to adopt these standards starting in the first quarter of fiscal year 2019 using either of two methods: (i) retrospective to each prior reporting period presented with the option to elect certain practical expedients as defined within the standard; or (ii) retrospective with the cumulative effect of initially applying the standard recognized at the date of initial application and providing certain additional disclosures as defined per the standard. The Company has not yet selected a transition method, and is in the process of determining the impact that the new standard will have on its Condensed Consolidated Financial Statements. The Company does not plan to early adopt this standard. In April 2015, the FASB released ASU 2015-3, “Interest – Imputation of Interest.” The amendment requires that debt issuance costs related to recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The Company adopted this standard in the September 2016 quarter, with retrospective application to the June 26, 2016 Condensed Consolidated Balance Sheet. The adoption did not have a material impact to the Condensed Consolidated Financial Statements. In September 2015, the FASB released ASU 2015-16, “Business Combinations - Simplifying the Accounting for Measurement-Period Adjustments,” which eliminates the requirement to restate prior period financial statements for measurement period adjustments. Instead, the cumulative impact of measurement period adjustments, including the impact on prior periods, is required to be recognized in the reporting period in which the adjustment is identified. The Company adopted this standard in the September 2016 quarter, with no impact to the Condensed Consolidated Financial Statements. In November 2015, the FASB issued ASU 2015-17, “Balance Sheet Classification of Deferred Taxes.” This ASU amends existing guidance to require that deferred income tax assets and liabilities be classified as non-current in a classified balance sheet, and eliminates the prior guidance which required an entity to separate deferred tax assets and liabilities into a current amount and a non-current amount in a classified balance sheet. The amendments in this ASU are effective for the Company beginning in its first quarter of fiscal year 2018. Earlier application is permitted as of the beginning of an interim or annual period. Additionally, the new guidance may be applied either prospectively to all deferred tax assets and liabilities or retrospectively to all periods presented. The Company is evaluating the timing of adoption, but plans to adopt the guidance prospectively with an anticipated reclassification from current assets and liabilities to non-current assets and liabilities on its Condensed Consolidated Balance Sheet. In January 2016, FASB released ASU 2016-1, “Financial Instruments - Overall - Recognition and Measurement of Financial Assets and Financial Liabilities.” The amendment changes the accounting for and financial statement presentation of equity investments, other than those accounted for under the equity method of accounting or those that result in consolidation of the investee. The amendment provides clarity on the measurement methodology to be used for the required disclosure of fair value of financial instruments measured at amortized cost on the balance sheet and clarifies that an entity should evaluate the need for a valuation allowance on deferred tax assets related to available-for-sale securities in combination with the entity's other deferred tax assets, among other changes. The Company is required to adopt this standard starting in the first quarter of fiscal year 2019 and does not anticipate that implementation will have a material impact on its Condensed Consolidated Financial Statements. In January 2016, FASB released ASU 2016-2, "Leases." The amendment requires an entity to recognize right-of-use assets and lease liabilities on its balance sheet and disclose key information about leasing arrangements. The amendment offers specific accounting guidance for a lessee, a lessor and sale and leaseback transactions. Lessees and lessors are required to disclose qualitative and quantitative information about leasing arrangements to enable a user of the financial statements to assess the amount, timing and uncertainty of cash flows arising from leases. The Company is required to adopt this standard starting in the first quarter of fiscal year 2020. Early adoption is permitted. The Company is currently in the process of evaluating the impact of adoption on its Condensed Consolidated Financial Statements. In March 2016, FASB released ASU 2016-9, "Compensation - Stock Compensation." Key changes in the amendment include: • entities will be required to recognize all excess tax benefits or deficiencies as an income tax benefit or expense in the income statement, eliminating APIC pools; • entities will no longer be required to delay recognition of excess tax benefits until they are realized; • entities will be required to classify the excess tax benefits as an operating activity in the statement of cash flows; • entities will be allowed to elect an accounting policy to either estimate the number of forfeitures, or account for forfeitures as they occur; and • entities can withhold up to the maximum individual statutory tax rate without classifying the awards as a liability, the cash paid to satisfy the statutory income tax withholding obligations shall be classified as a financing activity in the statement of cash flows. The Company is required to adopt this standard starting in the first quarter of fiscal year 2018. The Company is currently in the process of evaluating the impact of adoption on its Condensed Consolidated Financial Statements. In June 2016, FASB released ASU 2016-13, "Financial Instruments - Credit Losses." The amendment revises the impairment model to utilize an expected loss methodology in place of the currently used incurred loss methodology, which will result in more timely recognition of losses on financial instruments, including, but not limited to, available for sale debt securities and accounts receivable. The Company is required to adopt this standard starting in the first quarter of fiscal year 2021. Early adoption is permitted. The Company is currently in the process of evaluating the impact of adoption on its Condensed Consolidated Financial Statements.

EQUITY-BASED COMPENSATION PLANS

EQUITY-BASED COMPENSATION PLANS	3 Months Ended
	Sep. 25, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
EQUITY-BASED COMPENSATION PLANS	EQUITY-BASED COMPENSATION PLANS The Company has stock plans that provide for grants of equity-based awards to eligible participants, including stock options, restricted stock units (“RSUs”), and market-based performance RSUs (“market-based PRSUs”) of Lam Research common stock (“Common Stock”). An option is a right to purchase Common Stock at a set price. An RSU award is an agreement to issue a set number of shares of Common Stock at the time of vesting. The Company’s market-based PRSUs contain both a market condition and a service condition. The Company’s options, RSU and market-based PRSU awards typically vest over a period of three years . The Company also has an employee stock purchase plan that allows employees to purchase its Common Stock at a discount through payroll deductions. The Company recognized the following equity-based compensation expense and related income tax benefit in the Condensed Consolidated Statements of Operations: Three Months Ended September 25, September 27, (in thousands) Equity-based compensation expense $ 38,595 $ 35,774 Income tax benefit recognized related to equity-based compensation expense $ 10,905 $ 6,097 The estimated fair value of the Company’s stock-based awards, less expected forfeitures, is amortized over the awards’ vesting term on a straight-line basis. Stock Options and RSUs The Lam Research Corporation 2015 Stock Incentive Plan, as amended, 2007 Stock Incentive Plan, as amended and 2011 Stock Incentive Plan, as amended (collectively the “Stock Plans”) provide for the grant of non-qualified equity-based awards to eligible employees and non-employee directors of the Company and its subsidiaries. A summary of stock plan transactions is as follows: Options Outstanding Restricted Stock Units Outstanding Number of Weighted- Number of Weighted- June 26, 2016 907,411 $ 47.41 4,335,104 $ 69.30 Granted — $ — 34,458 $ 87.59 Exercised (54,364 ) $ 32.29 N/A N/A Canceled — $ — (50,640 ) $ 67.67 Vested restricted stock N/A N/A (61,540 ) $ 65.09 September 25, 2016 853,047 $ 48.37 4,257,382 $ 69.51 As of September 25, 2016 , there was $4.1 million of total unrecognized compensation cost related to unvested stock options granted and outstanding; that cost is expected to be recognized over a weighted-average remaining vesting period of 2.2 years . As of September 25, 2016 , there was $187.4 million of total unrecognized compensation expense related to unvested RSUs granted; that expense is expected to be recognized over a weighted-average remaining period of 2.0 years . ESPP The 1999 Employee Stock Purchase Plan, as amended and restated (the “1999 ESPP”), allows employees to designate a portion of their base compensation to be withheld through payroll deductions and used to purchase Common Stock at a purchase price per share equal to the lower of 85% of the fair market value of Common Stock on the first or last day of the applicable purchase period. Each offering period generally lasts up to 14 months and includes three interim purchase dates. Purchase rights under the 1999 ESPP were valued using the Black-Scholes option valuation model and the following weighted-average assumptions for the three months ended September 25, 2016 and September 27, 2015 : Three Months Ended September 25, September 27, Expected term (years) 0.77 0.68 Expected stock price volatility 33.02 % 31.56 % Risk-free interest rate 0.43 % 0.18 % Dividend Yield 1.14 % 0.93 % As of September 25, 2016 , there was $19.0 million of unrecognized compensation expense related to the 1999 ESPP, which is expected to be recognized over a remaining period of approximately 1.1 years .

OTHER EXPENSE, NET

OTHER EXPENSE, NET	3 Months Ended
	Sep. 25, 2016
Other Income and Expenses [Abstract]
OTHER EXPENSE, NET	OTHER EXPENSE, NET The significant components of other expense, net, are as follows: Three Months Ended September 25, September 27, (in thousands) Interest income $ 12,763 $ 5,760 Interest expense (41,429 ) (24,661 ) Gains (losses) on deferred compensation plan related assets, net 6,172 (5,164 ) Foreign exchange gains (losses), net 1,219 (698 ) Other, net (1,879 ) (2,358 ) $ (23,154 ) $ (27,121 ) Interest income in the three months ended September 25, 2016 increased, as compared to the three months ended September 27, 2015 , due to higher cash balances and increased interest rates. Interest expense in the three months ended September 25, 2016 increased, as compared to the three months ended September 27, 2015 , primarily due to interest expense associated with the $2.4 billion Senior Note issuance in the three months ended June 26, 2016 .

INCOME TAX EXPENSE

INCOME TAX EXPENSE	3 Months Ended
	Sep. 25, 2016
Income Tax Disclosure [Abstract]
INCOME TAX EXPENSE	INCOME TAX EXPENSE The Company recorded an income tax expense of $29.0 million for the three months ended September 25, 2016 , which yielded an effective tax rate of approximately 9.9% . The difference between the U.S. federal statutory tax rate of 35% and the Company’s effective tax rate for the three months ended September 25, 2016 is primarily due to income in lower tax jurisdictions .

NET INCOME PER SHARE

NET INCOME PER SHARE	3 Months Ended
	Sep. 25, 2016
Earnings Per Share [Abstract]
NET INCOME PER SHARE	NET INCOME PER SHARE Basic net income per share is computed by dividing net income by the weighted-average number of shares of Common Stock outstanding during the period. Diluted net income per share is computed using the treasury stock method, for dilutive stock options, RSUs, convertible notes, and warrants. Dilutive shares outstanding include the effect of the convertible notes. Refer to Note 11 for additional information regarding the Company's convertible notes. The following table reconciles the numerators and denominators of the basic and diluted computations for net income per share. Three Months Ended September 25, September 27, (in thousands, except per share data) Numerator: Net income $ 263,835 $ 288,679 Denominator: Basic average shares outstanding 160,607 158,352 Effect of potential dilutive securities: Employee stock plans 2,142 2,544 Convertible notes 15,220 13,120 Warrants 2,048 358 Diluted average shares outstanding 180,017 174,374 Net income per share - basic $ 1.64 $ 1.82 Net income per share - diluted $ 1.47 $ 1.66 For purposes of computing diluted net income per share, weighted-average common shares do not include potentially dilutive securities that are anti-dilutive under the treasury stock method. The following potentially dilutive securities were excluded: Three Months Ended September 25, September 27, (in thousands) Number of options and RSUs excluded 196 93 Diluted shares outstanding do not include any effect resulting from the note hedges associated with the Company’s 2018 Notes as their impact would have been anti-dilutive.

FINANCIAL INSTRUMENTS

FINANCIAL INSTRUMENTS	3 Months Ended
	Sep. 25, 2016
Fair Value Disclosures [Abstract]
FINANCIAL INSTRUMENTS	FINANCIAL INSTRUMENTS The Company maintains an investment portfolio of various holdings, types, and maturities. The Company’s mutual funds, which are related to the Company’s obligations under the deferred compensation plan, are classified as trading securities. Investments classified as trading securities are recorded at fair value based upon quoted market prices. Differences between the cost and fair value of trading securities are recognized as other income (expense) in the Condensed Consolidated Statements of Operations. All of the Company’s other investments are classified as available-for-sale and consequently are recorded in the Condensed Consolidated Balance Sheets at fair value with unrealized gains or losses reported as a separate component of accumulated other comprehensive income (loss), net of tax. Fair Value The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact, and it considers assumptions that market participants would use when pricing the asset or liability. A fair value hierarchy has been established that prioritizes the inputs to valuation techniques used to measure fair value. The level of an asset or liability in the hierarchy is based on the lowest level of input that is significant to the fair value measurement. Assets and liabilities carried at fair value are classified and disclosed in one of the following three categories: Level 1: Valuations based on quoted prices in active markets for identical assets or liabilities with sufficient volume and frequency of transactions. Level 2: Valuations based on observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or model-derived valuations techniques for which all significant inputs are observable in the market or can be corroborated by observable market data, for substantially the full term of the assets or liabilities. Level 3: Valuations based on unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities and based on non-binding, broker-provided price quotes and may not have been corroborated by observable market data. The Company’s primary financial instruments include its cash, cash equivalents, investments, restricted cash and investments, long-term investments, accounts receivable, accounts payable, long-term debt and capital leases, and foreign currency related derivative instruments. The estimated fair value of cash, accounts receivable and accounts payable approximates their carrying value due to the short period of time to their maturities. The estimated fair values of capital lease obligations approximate their carrying value as the substantial majority of these obligations have interest rates that adjust to market rates on a periodic basis. Refer to Note 11 for additional information regarding the fair value of the Company’s convertible notes senior notes. The following table sets forth the Company’s cash, cash equivalents, investments, restricted cash and investments, and other assets measured at fair value on a recurring basis as of September 25, 2016 and June 26, 2016 : September 25, 2016 (Reported Within) Cost Unrealized Unrealized Fair Value Cash and Investments Restricted Other (in thousands) Cash $ 768,071 $ — $ — $ 768,071 $ 762,458 $ — $ 5,613 $ — Level 1: Time Deposit 913,725 — — 913,725 663,698 — 250,027 — Money Market Funds 4,180,031 — — 4,180,031 4,180,031 — — — U.S. Treasury and Agencies 366,017 951 (3 ) 366,965 86,092 280,873 — — Mutual Funds 39,010 1,773 (195 ) 40,588 — — — 40,588 Level 1 Total 5,498,783 2,724 (198 ) 5,501,309 4,929,821 280,873 250,027 40,588 Level 2: Municipal Notes and Bonds 201,502 183 (76 ) 201,609 — 201,609 — — Government-Sponsored Enterprises 31,701 49 (14 ) 31,736 — 31,736 — — Foreign Government Bonds 14,357 20 (1 ) 14,376 — 14,376 — — Corporate Notes and Bonds 937,712 2,871 (201 ) 940,382 169,422 770,960 — — Mortgage Backed Securities — Residential 15,747 53 (141 ) 15,659 — 15,659 — — Mortgage Backed Securities — Commercial 37,661 18 (117 ) 37,562 — 37,562 — — Level 2 Total 1,238,680 3,194 (550 ) 1,241,324 169,422 1,071,902 — — Total $ 7,505,534 $ 5,918 $ (748 ) $ 7,510,704 $ 5,861,701 $ 1,352,775 $ 255,640 $ 40,588 June 26, 2016 (Reported Within) Cost Unrealized Unrealized Fair Value Cash and Investments Restricted Other (in thousands) Cash $ 418,216 $ — $ — $ 418,216 $ 412,573 $ — $ 5,643 $ — Level 1: Time Deposit 904,243 — — 904,243 659,465 — 244,778 — Money Market Funds 3,904,288 — — 3,904,288 3,904,288 — — — U.S. Treasury and Agencies 446,530 2,041 (2 ) 448,569 62,996 385,573 — — Mutual Funds 39,318 1,400 (397 ) 40,321 — — — 40,321 Level 1 Total 5,294,379 3,441 (399 ) 5,297,421 4,626,749 385,573 244,778 40,321 Level 2: Municipal Notes and Bonds 265,386 355 (16 ) 265,725 — 265,725 — — U.S. Treasury and Agencies 8,068 151 — 8,219 — 8,219 — — Government-Sponsored Enterprises 31,885 91 (13 ) 31,963 — 31,963 — — Foreign Government Bonds 41,440 76 (4 ) 41,512 — 41,512 — — Corporate Notes and Bonds 979,566 4,341 (566 ) 983,341 — 983,341 — — Mortgage Backed Securities — Residential 17,395 37 (152 ) 17,280 — 17,280 — — Mortgage Backed Securities — Commercial 55,129 30 (160 ) 54,999 — 54,999 — — Level 2 Total 1,398,869 5,081 (911 ) 1,403,039 — 1,403,039 — — Total $ 7,111,464 $ 8,522 $ (1,310 ) $ 7,118,676 $ 5,039,322 $ 1,788,612 $ 250,421 $ 40,321 The Company accounts for its investment portfolio at fair value. Realized gains (losses) for investment sales are specifically identified. Management assesses the fair value of investments in debt securities that are not actively traded through consideration of interest rates and their impact on the present value of the cash flows to be received from the investments. The Company also considers whether changes in the credit ratings of the issuer could impact the assessment of fair value. The Company did not recognize any losses on investments due to other-than-temporary impairments during the three months ended September 25, 2016 or September 27, 2015 . Additionally, gross realized gains and gross realized (losses) from sales of investments were approximately $2.6 million and $0.2 million , respectively, in the three months ended September 25, 2016 and $0.2 million and $0.7 million , respectively, in the three months ended September 27, 2015 . The following is an analysis of the Company’s cash, cash equivalents, investments, and restricted cash and investments in unrealized loss positions: September 25, 2016 Unrealized Losses Unrealized Losses Total Fair Value Gross Fair Value Gross Fair Value Gross (in thousands) Municipal Notes and Bonds $ 110,401 $ (71 ) $ 1,995 $ (5 ) $ 112,396 $ (76 ) U.S. Treasury & Agencies 8,247 (3 ) — — 8,247 (3 ) Mutual Funds — — 8,964 (195 ) 8,964 (195 ) Government-Sponsored Enterprises 419 — 621 (14 ) 1,040 (14 ) Foreign Government Bonds 4,250 (1 ) — — 4,250 (1 ) Corporate Notes and Bonds 147,348 (83 ) 47,805 (118 ) 195,153 (201 ) Mortgage Backed Securities — Residential 8,469 (57 ) 3,897 (84 ) 12,366 (141 ) Mortgage Backed Securities — Commercial 28,585 (82 ) 6,318 (35 ) 34,903 (117 ) $ 307,719 $ (297 ) $ 69,600 $ (451 ) $ 377,319 $ (748 ) The amortized cost and fair value of cash equivalents, investments and restricted investments with contractual maturities are as follows as of September 25, 2016 : Cost Estimated (in thousands) Due in one year or less $ 5,898,756 $ 5,898,959 Due after one year through five years 730,005 733,625 Due in more than five years 69,692 69,461 $ 6,698,453 $ 6,702,045 The Company has the ability, if necessary, to liquidate its investments in order to meet the Company’s liquidity needs in the next 12 months. Accordingly, those investments with contractual maturities greater than one year from the date of purchase nonetheless are classified as short-term on the accompanying Condensed Consolidated Balance Sheets. Derivative Instruments and Hedging The Company carries derivative financial instruments (“derivatives”) on its Condensed Consolidated Balance Sheets at their fair values. The Company enters into foreign currency forward derivative contracts and foreign currency options with financial institutions with the primary objective of reducing volatility of earnings and cash flows related to foreign currency exchange rate fluctuations. The counterparties to these derivative contracts are large global financial institutions that the Company believes are creditworthy, and therefore, it does not consider the risk of counterparty nonperformance to be material. Cash Flow Hedges The Company’s financial position is routinely subjected to market risk associated with foreign currency exchange rate fluctuations on non-U.S. dollar transactions or cash flows, primarily from Japanese yen-denominated revenues, and euro denominated and Korean won-denominated expenses. The Company’s policy is to mitigate the foreign exchange risk arising from the fluctuations in the value of these non-U.S. dollar denominated transactions or cash flows through a foreign currency cash flow hedging program, using forward contracts and foreign currency options that generally expire within 12 months and no later than 24 months . These hedge contracts are designated as cash flow hedges and are carried on the Company’s balance sheet at fair value with the effective portion of the contracts’ gains or losses included in accumulated other comprehensive income (loss) and subsequently recognized in revenue/expense in the same period the hedged items are recognized. In addition, the Company enters into forward-starting interest rate swap agreements to hedge against the variability of cash flows due to changes in certain benchmark interest rates on fixed rate debt. These instruments are designated as cash flow hedges at inception and are settled in conjunction with the issuance of debt. The effective portion of the contracts’ gain or loss is included in accumulated other comprehensive (loss) and is amortized into income as the hedged item impacts earnings. During fiscal year ended June 26, 2016 and June 28, 2015 , the Company entered into and settled a series of forward-starting interest rate swap agreements, with a total notional value of $600 million and $375 million , respectively, that were settled in conjunction with the issuance of debt during the three months ended June 26, 2016 and March 29, 2015, respectively. At inception and at each quarter end, hedges are tested prospectively and retrospectively for effectiveness using regression analysis. Changes in the fair value of the forward contracts due to changes in time value are excluded from the assessment of effectiveness and are recognized in revenue or expense in the current period. The change in time value related to these contracts was not material for all reported periods. Changes in the fair value of foreign exchange options due to changes in time value are included in the assessment of effectiveness. To qualify for hedge accounting, the hedge relationship must meet criteria relating both to the derivative instrument and the hedged item. These criteria include identification of the hedging instrument, the hedged item, the nature of the risk being hedged and how the hedging instrument’s effectiveness in offsetting the exposure to changes in the hedged item’s fair value or cash flows will be measured. There were no material gains or losses during three months ended September 25, 2016 and September 27, 2015 associated with ineffectiveness or forecasted transactions that failed to occur. To receive hedge accounting treatment, all hedging relationships are formally documented at the inception of the hedge and the hedges must be tested to demonstrate an expectation of providing highly effective offsetting changes to future cash flows on hedged transactions. When derivative instruments are designated and qualify as effective cash flow hedges, the Company recognizes effective changes in the fair value of the hedging instrument within accumulated other comprehensive income (loss) until the hedged exposure is realized. Consequently, with the exception of excluded time value associated with the forward contracts and hedge ineffectiveness recognized, the Company’s results of operations are not subject to fluctuation as a result of changes in the fair value of the derivative instruments. If hedges are not highly effective or if the Company does not believe that the underlying hedged forecasted transactions will occur, the Company may not be able to account for its derivative instruments as cash flow hedges. If this were to occur, future changes in the fair values of the Company’s derivative instruments would be recognized in earnings. Additionally, related amounts previously recorded in other comprehensive income would be reclassified to income immediately. As of September 25, 2016 , the Company had losses of $5.3 million accumulated in other comprehensive income, net of tax, related to foreign exchange cash flow hedges which it expects to reclassify from other comprehensive income into earnings over the next 12 months . Additionally, the Company had a net loss of $0.8 million accumulated in other comprehensive income, net of tax, related to interest rate contracts which it expects to reclassify from other comprehensive income into earnings over the next 9.7 years . As a result of the October 5, 2016 termination of the Agreement and Plan of Merger and Reorganization with KLA-Tencor Corporation ("KLA-Tencor") (see Note 15 for additional information), a gain of approximately $1.1 million accumulated in other comprehensive income, net of tax, related to interest rate contracts associated with the 2026 Notes (as defined in Note 11) will be reclassified into earnings in the three months ended December 25, 2016. Fair Value Hedges During the fiscal year ended June 26, 2016 , the Company entered into a series of interest rate contracts with a total notional value of $400 million whereby the Company receives fixed rates and pays variable rates based on certain benchmark interest rates, resulting in a net increase or decrease to interest expense, a component of Other expense, net in our Condensed Consolidated Statement of Operations. These interest rate contracts are designated as fair value hedges and hedge against changes in the fair value of our debt portfolio. The Company concluded that these interest rate contracts meet the criteria necessary to qualify for the short-cut method of hedge accounting, and as such an assumption is made that the change in the fair value of the hedged debt, due to changes in the benchmark rate, exactly offsets the change in the fair value of the interest rate swap. Therefore, the derivative is considered to be effective at achieving offsetting changes in the fair value of the hedged liability, and no ineffectiveness is recognized. Balance Sheet Hedges The Company also enters into foreign currency forward contracts to hedge fluctuations associated with foreign currency denominated monetary assets and liabilities, primarily third party accounts receivables, accounts payables and intercompany receivables and payables. These forward contracts are not designated for hedge accounting treatment. Therefore, the change in fair value of these derivatives is recorded as a component of other income (expense) and offsets the change in fair value of the foreign currency denominated assets and liabilities, which are also recorded in other income (expense). As of September 25, 2016 , the Company had the following outstanding foreign currency contracts that were entered into under its cash flow and balance sheet hedge program: Notional Value Derivatives Designated as Derivatives Not Designated (in thousands) Foreign Currency Forward Contracts Buy Contracts Sell Contracts Buy Contracts Sell Contracts Japanese yen $ — $ 104,039 $ — $ 181,405 Swiss franc — — 7,387 — Euro 24,049 — 31,518 — Korean won 5,740 — 9,402 — Chinese renminbi — — 8,215 Singapore dollar — — 33,867 — Taiwan dollar — — 22,790 — $ 29,789 $ 104,039 $ 113,179 $ 181,405 Foreign Currency Option Contracts Buy Put Sell Put Buy Put (1) Sell Put Japanese yen $ — $ — $ 15,695 $ 15,695 (1) Contracts were entered into and designated as cash flow hedges under ASC 815, contracts were subsequently de-designated, changes in fair market value subsequent to de-designation effect current earnings. The fair value of derivative instruments in the Company’s Condensed Consolidated Balance Sheets as of September 25, 2016 and June 26, 2016 were as follows: September 25, 2016 June 26, 2016 Fair Value of Derivative Instruments (Level 2) Fair Value of Derivative Instruments (Level 2) Asset Derivatives Liability Derivatives Asset Derivatives Liability Derivatives Balance Sheet Fair Value Balance Sheet Fair Value Balance Sheet Fair Value Balance Sheet Fair Value (in thousands) Derivatives designated as hedging instruments: Foreign exchange forward contracts Prepaid expense $ 113 Accrued liabilities $ 5,734 Prepaid expense $ 249 Accrued liabilities $ 16,585 Interest rate contracts, short-term Accrued expenses and other current liabilities 2,623 Prepaid expense — Accrued expenses and other current liabilities 50 Prepaid expense 159 Interest rate contracts, long-term Other assets 4,968 Other long-term liabilities — Other assets 8,661 Other long-term liabilities — Derivatives not designated as hedging instruments: Foreign exchange forward contracts Prepaid expense 279 Accrued 83 Prepaid expense 107 Accrued 1,529 Total derivatives $ 7,983 $ 5,817 $ 9,067 $ 18,273 Under the master netting agreements with the respective counterparties to the Company’s derivative contracts, subject to applicable requirements, the Company is allowed to net settle transactions of the same currency with a single net amount payable by one party to the other. However, the Company has elected to present the derivative assets and derivative liabilities on a gross basis on its balance sheet. As of September 25, 2016 , the potential effect of rights of off-set associated with the above foreign exchange and interest rate contracts would be an offset to assets and liabilities by $4.4 million , resulting in a net derivative asset of $3.6 million and net derivative liability of $1.4 million . As of June 26, 2016 , the potential effect of rights of set-off associated with the above foreign exchange contracts would be an offset to both assets and liabilities by $6.4 million , resulting in a net derivative asset of $2.7 million and a net derivative liability of $11.9 million . The Company is not required to pledge, nor is the Company entitled to receive, cash collateral for these derivative transactions. The effect of derivative instruments designated as cash flow hedges on the Company’s Condensed Consolidated Statements of Operations, including accumulated other comprehensive income (“AOCI”) was as follows: Three Months Ended September 25, 2016 Three Months Ended September 27, 2015 Effective Portion Ineffective Effective Portion Ineffective Location of Gain (Loss) Gain (Loss) Gain (Loss) Loss Gain (Loss) Gain (Loss) Derivatives Designated (in thousands) Foreign Exchange Contracts Revenue $ (2,913 ) $ (13,605 ) $ 705 $ (69 ) $ (1,378 ) $ 32 Foreign Exchange Contracts Cost of goods sold 235 173 (67 ) (415 ) 1,505 (22 ) Foreign Exchange Contracts Selling, general, and (24 ) (9 ) (21 ) (173 ) 258 (7 ) Interest Rate Contracts Other expense, net — 9 — — (94 ) — $ (2,702 ) $ (13,432 ) $ 617 $ (657 ) $ 291 $ 3 The effect of derivative instruments not designated as cash flow hedges on the Company’s Condensed Consolidated Statements of Operations was as follows: Three Months Ended September 25, 2016 September 27, 2015 Derivatives Not Designated as Hedging Instruments: Location Loss Recognized Gain (in thousands) Foreign Exchange Contracts Other $ (383 ) $ 6,007 Concentrations of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, investments, restricted cash and investments, trade accounts receivable, and derivative financial instruments used in hedging activities. Cash is placed on deposit at large global financial institutions. Such deposits may be in excess of insured limits. Management believes that the financial institutions that hold the Company’s cash are creditworthy and, accordingly, minimal credit risk exists with respect to these balances. The Company’s overall portfolio of available-for-sale securities must maintain an average minimum rating of “AA-” or “Aa3” as rated by Standard and Poor’s, Moody’s Investor Services, or Fitch Ratings. To ensure diversification and minimize concentration, the Company’s policy limits the amount of credit exposure with any one financial institution or commercial issuer. The Company is exposed to credit losses in the event of nonperformance by counterparties on foreign currency forward hedge contracts that are used to mitigate the effect of exchange rate fluctuations, and on contracts related to structured share repurchase arrangements. These counterparties are large global financial institutions and, to date, no such counterparty has failed to meet its financial obligations to the Company. Credit risk evaluations, including trade references, bank references and Dun & Bradstreet ratings, are performed on all new customers and the Company monitors its customers’ financial condition and payment performance. In general, the Company does not require collateral on sales.

INVENTORIES

INVENTORIES	3 Months Ended
	Sep. 25, 2016
Inventory Disclosure [Abstract]
INVENTORIES	INVENTORIES Inventories are stated at the lower of cost (first-in, first-out method) or market. System shipments to Japanese customers, for which title does not transfer until customer acceptance, are classified as finished goods inventory and carried at cost until title transfers. Inventories consist of the following: September 25, June 26, (in thousands) Raw materials $ 549,406 $ 536,844 Work-in-process 139,120 151,406 Finished goods 243,055 283,661 $ 931,581 $ 971,911

GOODWILL AND INTANGIBLE ASSETS

GOODWILL AND INTANGIBLE ASSETS	3 Months Ended
	Sep. 25, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
GOODWILL AND INTANGIBLE ASSETS	GOODWILL AND INTANGIBLE ASSETS Goodwill The balance of goodwill is approximately $1.4 billion as of September 25, 2016 and June 26, 2016 . As of September 25, 2016 , $61.1 million of the goodwill balance is tax deductible and the remaining balance is not tax deductible due to purchase accounting and applicable foreign law. Intangible Assets The following table provides the Company’s intangible assets as of September 25, 2016 : Gross Accumulated Net (in thousands) Customer relationships $ 615,193 $ (317,130 ) $ 298,063 Existing technology 643,261 (422,518 ) 220,743 Patents 36,553 (29,335 ) 7,218 Other intangible assets 36,114 (35,545 ) 569 Total intangible assets $ 1,331,121 $ (804,528 ) $ 526,593 The following table provides the Company’s intangible assets as of June 26, 2016 : Gross Accumulated Net (in thousands) Customer relationships $ 615,272 $ (300,711 ) $ 314,561 Existing technology 643,433 (401,036 ) 242,397 Patents 36,053 (28,701 ) 7,352 Other intangible assets 36,114 (35,503 ) 611 Total intangible assets $ 1,330,872 $ (765,951 ) $ 564,921 The Company recognized $38.7 million and $39.0 million in intangible asset amortization expense during the three months ended September 25, 2016 and September 27, 2015 , respectively. The estimated future amortization expense of intangible assets, excluding those with indefinite lives, as of September 25, 2016 was as follows: Fiscal Year Amount (in thousands) 2017 (remaining 9 months) $ 116,002 2018 153,337 2019 115,263 2020 50,194 2021 47,792 Thereafter 44,005 $ 526,593

ACCRUED EXPENSES AND OTHER CURR

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES	3 Months Ended
	Sep. 25, 2016
Payables and Accruals [Abstract]
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES	ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES Accrued expenses and other current liabilities consist of the following: September 25, June 26, (in thousands) Accrued compensation $ 357,134 $ 331,528 Warranty reserves 103,226 100,321 Income and other taxes payable 68,057 86,723 Dividend payable 48,397 48,052 Other 188,841 206,286 $ 765,655 $ 772,910

LONG-TERM DEBT AND OTHER BORROW

LONG-TERM DEBT AND OTHER BORROWINGS	3 Months Ended
	Sep. 25, 2016
Debt Disclosure [Abstract]
LONG-TERM DEBT AND OTHER BORROWINGS	LONG-TERM DEBT AND OTHER BORROWINGS As of September 25, 2016 and June 26, 2016 , the Company's outstanding debt consisted of the following: September 25, 2016 June 26, 2016 Amount (in thousands) Effective Interest Rate Amount (in thousands) Effective Interest Rate Fixed-rate 1.25% Convertible Notes Due May 15, 2018 ("2018 Notes") $ 449,947 (1) 5.27 % $ 449,954 (3) 5.27 % Fixed-rate 2.75% Senior Notes Due March 15, 2020 ("2020 Notes") 500,000 2.88 % 500,000 2.88 % Fixed-rate 2.80% Senior Notes Due June 15, 2021 ("2021 Notes") 800,000 2.95 % 800,000 2.95 % Fixed-rate 3.45% Senior Notes Due June 15, 2023 ("2023 Notes") 600,000 3.60 % 600,000 3.60 % Fixed-rate 3.80% Senior Notes Due March 15, 2025 ("2025 Notes") 500,000 3.87 % 500,000 3.87 % Fixed-rate 3.90% Senior Notes Due June 15, 2026 ("2026 Notes") 1,000,000 4.01 % 1,000,000 4.01 % Fixed-rate 2.625% Convertible Notes Due May 15, 2041 ("2041 Notes") 699,883 (1) 4.28 % 699,895 (3) 4.28 % Total debt outstanding, at par 4,549,830 4,549,849 Unamortized discount (226,811 ) (232,727 ) Fair value adjustment - interest rate contracts 7,592 8,552 Unamortized bond issuance costs (6,781 ) (7,213 ) (4) Total debt outstanding, at carrying value $ 4,323,830 $ 4,318,461 Reported as: Current portion of long-term debt $ 945,836 (2) $ 940,537 (2) Long-term debt 3,377,994 3,377,924 Total debt outstanding, at carrying value $ 4,323,830 $ 4,318,461 ____________________________ (1) As of September 25, 2016 , these notes were convertible at the option of the bondholder, as a result of the condition described in (2) below. Upon closure of the conversion period, Notes not converted will be reclassified back into noncurrent liabilities and the temporary equity will be reclassified into permanent equity. (2) As of the report date the market value of the Company's Common Stock was greater than 130% of the convertible notes conversion price for 20 or more of the 30 consecutive trading days preceding the quarter-end. As a result, the convertible notes were classified in current liabilities and a portion of the equity component, representing the unamortized discount, was classified in temporary equity on the Company's Consolidated Balance Sheets. (3) As of June 26, 2016 , these notes were convertible at the option of the bond holder, as a result of the condition described in (2) above. (4) The Company adopted ASU 2015-3, regarding the simplification of the presentation of bond issuance costs, which requires that bond issuance costs related to a recognized liability be presented on the balance sheet as a direct reduction from the carrying amount of that debt liability, consistent with debt discounts. The Company applied the accounting standard update on a retrospective basis by reclassifying the presentation of bond issuance costs totaling $1.76 million which was originally included in prepaid assets and other current assets against current portion of convertible notes and capital leases, and $5.45 million which was originally included in other assets against senior notes, convertible notes, and capital leases, less current portion on the Condensed Consolidated Balance Sheets for June 26, 2016 . There is no impact to the Company's Condensed Consolidated Statements of Operation, Stockholders' Equity, or Cash Flows for the fiscal year ended June 26, 2016 . Convertible Senior Notes In May 2011, the Company issued and sold $450 million in aggregate principal amount of 1.25% Convertible Senior Notes due May 2018 (the “2018 Notes”) at par. The Company pays cash interest at an annual rate of 1.25% , on the 2018 Notes, on a semi-annual basis on May 15 and November 15 of each year. In June 2012, with the acquisition of Novellus, the Company assumed $700 million in aggregate principal amount of 2.625% Convertible Senior Notes due May 2041 (the “2041 Notes,” and collectively with the 2018 Notes, the “Convertible Notes”). The Company pays cash interest at an annual rate of 2.625% , on a semi-annual basis on May 15 and November 15 of each year on the 2041 Notes. The 2041 Notes also have a contingent interest payment provision that may require the Company to pay additional interest, up to 0.60% per year, based on certain thresholds, beginning with the semi-annual interest payment on May 15, 2021, and upon the occurrence of certain events, as outlined in the indenture governing the 2041 Notes. The Company separately accounts for the liability and equity components of the Convertible Notes. The initial debt components of the Convertible Notes were valued based on the present value of the future cash flows using the Company’s borrowing rate at the date of the issuance or assumption for similar debt instruments without the conversion feature, which equals the effective interest rate on the liability component disclosed in the table below, respectively. The equity component was initially valued equal to the principle value of the notes, less the present value of the future cash flows using the Company’s borrowing rate at the date of the issuance or assumption for similar debt instruments without a conversion feature, which equated to the initial debt discount. Under certain circumstances, the Convertible Notes may be converted into shares of the Company’s Common Stock. The number of shares each debenture is convertible into is based on conversion rates, disclosed in the table below. Conversions in the three months ended September 25, 2016 were not material. Selected additional information regarding the Convertible Notes outstanding as of September 25, 2016 and June 26, 2016 , the Convertible Notes consisted of the following: September 25, 2016 June 26, 2016 2018 Notes 2041 Notes 2018 Notes 2041 Notes (in thousands, except years, percentages, conversion rate, and conversion price) Carrying amount of permanent equity component, net of tax $ 77,064 $153,384 $ 72,992 $ 152,397 Carrying amount of temporary equity component, net of tax $ 27,818 $ 174,649 $ 31,894 $ 175,658 Remaining amortization period (years) 1.6 24.6 1.9 24.9 Fair Value of Notes (Level 2) $ 701,242 $ 1,906,194 Conversion rate (shares of common stock per $1,000 principal amount of notes) 16.3893 29.4126 Conversion price (per share of common stock) $ 61.02 $ 34.00 If-converted value in excess of par value $ 226,868 $ 1,189,443 Estimated share dilution using average quarterly stock price $90.25 per share 2,389 12,830 Convertible Note Hedges and Warrants Concurrent with the issuance of the 2018 Notes and $450 million of notes that matured in May of 2016 (the "2016 Notes"), the Company purchased a convertible note hedge and sold warrants. The warrants settlement is contractually defined as net share settlement. The exercise price is adjusted for certain corporate events, including dividends on the Company’s Common Stock. During the three months ended September 25, 2016 , warrants associated with the 2016 Notes were exercised resulting in the issuance of approximately 1.1 million shares of the Company's Common Stock. As of September 25, 2016 , the warrants associated with the 2018 Notes had not been exercised and remained outstanding. In conjunction with the convertible note hedge, counterparties agreed to sell to the Company shares of Common Stock equal to the number of shares issuable upon conversion of the 2018 Notes in full. The convertible note hedge transactions will be settled in net shares and will terminate upon the earlier of the maturity date or the first day none of the respective notes remain outstanding due to conversion or otherwise. Settlement of the convertible note hedge in net shares, based on the number of shares issued upon conversion of the 2018 Notes, on the expiration date would result in the Company receiving net shares equivalent to the number of shares issuable by the Company upon conversion of the 2018 Notes. The exercise price is adjusted for certain corporate events, including dividends on the Company’s Common Stock. The following table presents the details of the warrants and convertible note hedge arrangements as of September 25, 2016 : 2016 Notes 2018 Notes (shares in thousands) Warrants: Underlying shares 3,098 7,375 Estimated share dilution using average quarterly stock price $90.25 per share 694 1,354 Exercise price $ 69.07 $ 73.68 Expiration date range August 15 - October 21, 2016 August 15 - October 23, 2018 Convertible Note Hedge: Number of shares available from counterparties — 7,374 Exercise price $ — $ 61.02 Senior Notes On March 12, 2015, the Company completed a public offering of $500 million aggregate principal amount of the Company’s Senior Notes due March, 2020 (the “2020 Notes”) and $500 million aggregate principal amount of the Company’s Senior Notes due March, 2025 (the “2025 Notes” and, together with the 2020 Notes, the “Senior Notes”). The Company pays interest at an annual rate of 2.75% and 3.80% , respectively, on the 2020 Notes and 2025 Notes, on a semi-annual basis on March 15 and September 15 of each year. During the year ended June 26, 2016 , the Company entered into a series of interest rate contracts hedging the fair value of a portion of the 2025 Notes par value, whereby the Company receives a fixed rate and pays a variable rate based on a certain benchmark interest rate. Refer to Note 7 for additional information regarding these interest rate contracts. The Company may redeem the Senior Notes at a redemption price equal to 100% of the principal amount of such series (“par”), plus a “make whole” premium as described in the indenture in respect of the Senior Notes and accrued and unpaid interest before February 15, 2020 , for the 2020 Notes and before December 15, 2024 for the 2025 Notes. The Company may redeem the Senior Notes at par, plus accrued and unpaid interest at any time on or after February 15, 2020 for the 2020 Notes and on or after December 24, 2024 for the 2025 Notes. In addition, upon the occurrence of certain events, as described in the indenture, the Company will be required to make an offer to repurchase the Senior Notes at a price equal to 101% of the principal amount of the Senior Notes, plus accrued and unpaid interest. On June 7, 2016, The Company completed a public offering of $800.0 million aggregate principal amount of Senior Notes due June 2021 (the "2021 Notes"), $600.0 million aggregate principal amount of Senior Notes due June 2023 (the "2023 Notes") and $1.0 billion aggregate principal amount of Senior Notes due June 2026 (the "2026 Notes" together with the 2020, 2021, 2023, and 2025 Notes, the “Senior Notes”). The Company will pay interest at an annual rate of 2.80% , 3.45% and 3.90% , respectively, on the 2021 Notes, 2023 Notes and 2026 Notes, on a semi-annual basis on June 15 and December 15 of each year, beginning December 15, 2016. As a result of the October 5, 2016 termination of the Agreement and Plan of Merger and Reorganization with KLA-Tencor (see Note 15 for additional information), the 2023 Notes and the 2026 Notes were redeemed on October 13, 2016 under the Special Mandatory Redemption terms of the indenture governing these Notes. The Company was required to redeem all of the 2023 Notes and the 2026 Notes then outstanding, at a special mandatory redemption price equal to 101% of the aggregate principal amount of such notes, plus accrued and unpaid interest of approximately $21.0 million from the date of initial issuance. In addition, in conjunction with the Special Mandatory Redemption of the 2023 Notes and the 2026 Notes in the three months ended December 25, 2016, the Company will recognize approximately $2.5 million of loan issuance costs to other expense, net. The 2021 Notes are not subject to Special Mandatory Redemption. The Company may redeem the 2021 Notes at a redemption price equal to 100% of the principal amount of such series (“par”), plus a “make whole” premium as described in the indenture in respect to the 2021 Notes and accrued and unpaid interest before May 15, 2021. The Company may redeem the 2021 Notes at par, plus accrued and unpaid interest at any time on or after May 15, 2021. In addition, upon the occurrence of certain events, as described in the indenture, the Company will be required to make an offer to repurchase the 2021 Notes at a price equal to 101% of the principal amount of the respective note, plus accrued and unpaid interest. Selected additional information regarding the Senior Notes outstanding as of September 25, 2016 is as follows: Remaining Amortization period Fair Value of Notes (Level 2) (years) (in thousands) 2020 Notes 3.4 $ 501,375 2021 Notes 4.7 $ 821,224 2023 Notes * $ 615,000 2025 Notes 8.4 $ 514,100 2026 Notes * $ 1,046,340 * As a result of the October 5, 2016 termination of the Agreement and Plan of Merger and Reorganization with KLA-Tencor (see Note 15 for additional information), the 2023 Notes and the 2026 Notes were redeemed on October 13, 2016 under the Special Mandatory Redemption terms of the indenture governing these Notes. Interest Cost The following table presents the amount of interest cost recognized relating to both the contractual interest coupon and amortization of the debt discount, issuance costs, and effective portion of interest rate contracts with respect to the Convertible Notes, the Senior Notes, the term loan agreement and the revolving credit facility during the three months ended September 25, 2016 and September 27, 2015 . Three Months Ended September 25, September 27, (in thousands) Contractual interest coupon $ 34,712 $ 14,451 Amortization of interest discount 5,914 9,122 Amortization of issuance costs 918 652 Effect of interest rate contracts, net (1,058 ) 94 Total interest cost recognized $ 40,486 $ 24,319 Term Loan Agreement On May 13, 2016, we entered into an Amended and Restated Term Loan Agreement (the “Amended and Restated Term Loan Agreement”), which amends and restates the Term Loan Agreement we entered into on November 10, 2015 with a syndicate of lenders. The Amended and Restated Term Loan Agreement provides for a commitment of $1,530.0 million senior unsecured term loan facility composed of two tranches (the "Commitments"); (i) a $1,005.0 million tranche of 3-year senior unsecured loans; and (ii) a $525.0 million tranche of 5-year senior unsecured loans. The Commitments automatically terminated on October 5, 2016, upon termination of the Agreement and Plan of Merger and Reorganization with KLA-Tencor Corporation (see Note 15 for additional detail). In conjunction with the termination of the Commitments the Company will release approximately $3.7 million of loan issuance costs to other expense, net in the three months ended December 25, 2016. Revolving Credit Facility On November 10, 2015, we entered into an Amendment and Restatement Agreement (as amended on April 26, 2016 by Amendment No. 1 to the Amended and Restated Credit Agreement, and as further amended, restated, supplemented or otherwise modified from time to time, the “Amended and Restated Credit Agreement”), which amends and restates the Company's prior unsecured Credit Agreement, dated March 12, 2014 (as amended by Amendment No. 1, dated March 5, 2015). The Amended and Restated Credit Agreement provides for an increase to our revolving unsecured credit facility, from $300.0 million to $750.0 million with a syndicate of lenders. It includes an expansion option, subject to certain requirements, for us to request an increase in the facility of up to an additional $250.0 million , for a potential total commitment of $1.0 billion . Proceeds from the credit facility can be used for general corporate purposes. The facility matures on November 10, 2020. Termination of the Agreement and Plan of Merger and Reorganization with KLA-Tencor Corporate has no effect to the Amended and Restated Credit Agreement. Interest on amounts borrowed under the credit facility is, at the Company’s option, based on (i) a base rate, defined as the greatest of (a) prime rate, (b) Federal Funds rate plus 0.5% , or (c) one-month LIBOR plus 1.0% , plus a spread of 0.0% to 0.5% , or (ii) LIBOR multiplied by the statutory rate, plus a spread of 0.9% to 1.5% in each case as the applicable spread is determined based on the rating of the Company’s non-credit enhanced, senior unsecured long-term debt. Principal and any accrued and unpaid interest is due and payable upon maturity. Additionally, the Company will pay the lenders a quarterly commitment fee that varies based on the Company’s credit rating. The Restated Credit Agreement contains affirmative covenants, negative covenants, financial covenants and events of default that are substantially similar to those in the Amended and Restated Term Loan Agreement. As of September 25, 2016 , the Company had no borrowings outstanding under the credit facility and was in compliance with all financial covenants.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	3 Months Ended
	Sep. 25, 2016
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	COMMITMENTS AND CONTINGENCIES Operating Leases and Related Guarantees The Company leases certain of its administrative, research and development (“R&D”) and manufacturing facilities, regional sales/service offices, and certain equipment under non-cancelable operating leases. Certain of the Company’s facility leases for buildings located at its Fremont, California headquarters and certain other facility leases provide the Company with options to extend the leases for additional periods or to purchase the facilities. Certain of the Company’s facility leases provide for periodic rent increases based on the general rate of inflation. The Company has operating leases regarding certain improved properties in Fremont and Livermore, California (the “Operating Leases”). The Company was required to maintain cash collateral in an aggregate of approximately $250.0 million in separate interest-bearing accounts as security for the Company’s obligations. These amounts are recorded with other restricted cash and investments in the Company’s Condensed Consolidated Balance Sheet as of September 25, 2016 . During the term of the Operating Leases and when the terms of the Operating Leases expire, the property subject to those Operating Leases may be remarketed. The Company has guaranteed to the lessor that each property will have a certain minimum residual value. The aggregate guarantee made by the Company under the Operating Leases is generally no more than approximately $220.4 million ; however, under certain default circumstances, the guarantee with regard to an Operating Lease may be 100% of the lessor’s aggregate investment in the applicable property, which in no case will exceed $250.0 million , in the aggregate. Other Guarantees The Company has issued certain indemnifications to its lessors for taxes and general liability under some of its agreements. The Company has entered into certain insurance contracts that are intended to limit its exposure to such indemnifications. As of September 25, 2016 , the Company had not recorded any liability in connection with these indemnifications, as it does not believe, based on information available, that it is probable that any amounts will be paid under these guarantees. Generally, the Company indemnifies, under pre-determined conditions and limitations, its customers for infringement of third party intellectual property rights by the Company’s products or services. The Company seeks to limit its liability for such indemnity to an amount not to exceed the sales price of the products or services subject to its indemnification obligations. The Company does not believe, based on information available, that it is probable that any material amounts will be paid under these guarantees. The Company provides guarantees and standby letters of credit to certain parties as required for certain transactions initiated during the ordinary course of business. As of September 25, 2016 , the maximum potential amount of future payments that it could be required to make under these arrangements and letters of credit was $13.0 million . The Company does not believe, based on historical experience and information currently available, that it is probable that any amounts will be required to be paid. Warranties The Company provides standard warranties on its systems. The liability amount is based on actual historical warranty spending activity by type of system, customer, and geographic region, modified for any known differences such as the impact of system reliability improvements. Changes in the Company’s product warranty reserves were as follows: Three Months Ended September 25, September 27, (in thousands) Balance at beginning of period $ 100,321 $ 93,209 Warranties issued during the period 34,855 34,203 Settlements made during the period (32,228 ) (28,458 ) Changes in liability for pre-existing warranties 278 14 Balance at end of period $ 103,226 $ 98,968 Legal proceedings While the Company is not currently a party to any legal proceedings that it believes material, the Company is either a defendant or plaintiff in various actions that have arisen from time to time in the normal course of business, including intellectual property claims. The Company accrues for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Significant judgment is required in both the determination of probability and the determination as to whether a loss is reasonably estimable. To the extent there is a reasonable possibility that the losses could exceed the amounts already accrued, the Company believes that the amount of any such additional loss would be immaterial to the Company’s business, financial condition, and results of operations.

STOCK REPURCHASE PROGRAM

STOCK REPURCHASE PROGRAM	3 Months Ended
	Sep. 25, 2016
Equity [Abstract]
STOCK REPURCHASE PROGRAM	STOCK REPURCHASE PROGRAM On April 29, 2014, the Board of Directors authorized the repurchase of up to $850 million of Common Stock. These repurchases can be conducted on the open market or as private purchases and may include the use of derivative contracts with large financial institutions, in all cases subject to compliance with applicable law. Repurchases will be funded using the Company’s on-shore cash and on-shore cash generation. This repurchase program has no termination date and may be suspended or discontinued at any time. As of September 25, 2016 the Company has approximately $229.1 million available for purchase under this repurchase program. The Company suspended share repurchase activity under the repurchase program and made no share repurchases during the three months ended September 25, 2016 . The Company continues to withhold shares through net share settlements to cover minimum tax withholding obligations upon the vesting of restricted stock unit awards granted under the Company’s equity compensation plans, during the three months ended September 25, 2016 , the Company acquired 20,475 shares at a total cost of $1.9 million related to tax withholding. The shares retained by the Company through these net share settlements are not a part of the Board-authorized repurchase program but instead are authorized under the Company’s equity compensation plan.

ACCUMULATED OTHER COMPREHENSIVE

ACCUMULATED OTHER COMPREHENSIVE LOSS	3 Months Ended
	Sep. 25, 2016
Equity [Abstract]
ACCUMULATED OTHER COMPREHENSIVE LOSS	ACCUMULATED OTHER COMPREHENSIVE LOSS The components of accumulated other comprehensive income (loss) (“AOCI”), net of tax at the end of the period, as well as the activity during the period, were as follows: Accumulated foreign Accumulated Accumulated Accumulated Total (in thousands) Balance as of June 26, 2016 $ (39,528 ) $ (15,623 ) $ 4,896 $ (19,078 ) $ (69,333 ) Other comprehensive income (loss) before reclassifications 4,302 (2,421 ) (2,723 ) 123 (719 ) Losses reclassified from accumulated other comprehensive income (loss) to net income 199 (2) 11,950 (1) 903 (2) — 13,052 Net current-period other comprehensive income (loss) $ 4,501 $ 9,529 $ (1,820 ) $ 123 $ 12,333 Balance as of September 25, 2016 $ (35,027 ) $ (6,094 ) $ 3,076 $ (18,955 ) $ (57,000 ) (1) Amount of after tax gain reclassified from AOCI into net income located in revenue: $12,094 loss; cost of goods sold: $147 gain; selling, general and administrative expenses: $9 loss; and other income and expense: $6 gain. (2) Amount of after tax gain reclassified from accumulated other comprehensive income into net income located in other expense, net.

BUSINESS COMBINATIONS

BUSINESS COMBINATIONS	3 Months Ended
	Sep. 25, 2016
Business Combinations [Abstract]
BUSINESS COMBINATIONS	BUSINESS COMBINATIONS On October 20, 2015, the Company entered into an Agreement and Plan of Merger and Reorganization with KLA-Tencor Corporation. On October 5, 2016, the Company and KLA-Tencor announced that they had mutually agreed to terminate their previously announced Agreement and Plan of Merger and Reorganization. No termination fee is payable by either the Company or KLA-Tencor. During the three months ended September 25, 2016 the Company expensed acquisition-related costs as incurred of $10.0 million , within selling, general, and administrative expense in the Condensed Consolidated Statement of Operations.

BASIS OF PRESENTATION (Policies

BASIS OF PRESENTATION (Policies)	3 Months Ended
	Sep. 25, 2016
Accounting Policies [Abstract]
Consolidation	The condensed consolidated financial statements include the accounts of Lam Research and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.
Fiscal period	The Company’s reporting period is a 52/53-week fiscal year. The Company’s current fiscal year will end June 25, 2017 and includes 52 weeks.
Recent accounting pronouncements	In May 2014, the FASB released Accounting Standards Update (“ASU”) 2014-9, “Revenue from Contracts with Customers” to supersede nearly all existing revenue recognition guidance under GAAP. The core principle of the standard is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration that is expected to be received for those goods or services. The new standard defines a five step process to achieve this core principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing GAAP, including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. In April 2016, FASB released ASU 2016-10, "Revenue from Contracts with Customers." The amendment clarifies guidance in ASU 2014-09, “Revenue from Contracts with Customers” to improve guidance on criteria in assessing whether promises to transfer goods and services are separately identifiable and improve the understanding of the licensing implementation guidance. In May 2016, FASB released ASU 2016-12, "Revenue from Contracts with Customers." which also clarifies guidance in ASU 2014-09 on assessing collectability, non-cash consideration, presentation of sales tax and completed contracts and contract modification in transition. The Company is required to adopt these standards starting in the first quarter of fiscal year 2019 using either of two methods: (i) retrospective to each prior reporting period presented with the option to elect certain practical expedients as defined within the standard; or (ii) retrospective with the cumulative effect of initially applying the standard recognized at the date of initial application and providing certain additional disclosures as defined per the standard. The Company has not yet selected a transition method, and is in the process of determining the impact that the new standard will have on its Condensed Consolidated Financial Statements. The Company does not plan to early adopt this standard. In April 2015, the FASB released ASU 2015-3, “Interest – Imputation of Interest.” The amendment requires that debt issuance costs related to recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The Company adopted this standard in the September 2016 quarter, with retrospective application to the June 26, 2016 Condensed Consolidated Balance Sheet. The adoption did not have a material impact to the Condensed Consolidated Financial Statements. In September 2015, the FASB released ASU 2015-16, “Business Combinations - Simplifying the Accounting for Measurement-Period Adjustments,” which eliminates the requirement to restate prior period financial statements for measurement period adjustments. Instead, the cumulative impact of measurement period adjustments, including the impact on prior periods, is required to be recognized in the reporting period in which the adjustment is identified. The Company adopted this standard in the September 2016 quarter, with no impact to the Condensed Consolidated Financial Statements. In November 2015, the FASB issued ASU 2015-17, “Balance Sheet Classification of Deferred Taxes.” This ASU amends existing guidance to require that deferred income tax assets and liabilities be classified as non-current in a classified balance sheet, and eliminates the prior guidance which required an entity to separate deferred tax assets and liabilities into a current amount and a non-current amount in a classified balance sheet. The amendments in this ASU are effective for the Company beginning in its first quarter of fiscal year 2018. Earlier application is permitted as of the beginning of an interim or annual period. Additionally, the new guidance may be applied either prospectively to all deferred tax assets and liabilities or retrospectively to all periods presented. The Company is evaluating the timing of adoption, but plans to adopt the guidance prospectively with an anticipated reclassification from current assets and liabilities to non-current assets and liabilities on its Condensed Consolidated Balance Sheet. In January 2016, FASB released ASU 2016-1, “Financial Instruments - Overall - Recognition and Measurement of Financial Assets and Financial Liabilities.” The amendment changes the accounting for and financial statement presentation of equity investments, other than those accounted for under the equity method of accounting or those that result in consolidation of the investee. The amendment provides clarity on the measurement methodology to be used for the required disclosure of fair value of financial instruments measured at amortized cost on the balance sheet and clarifies that an entity should evaluate the need for a valuation allowance on deferred tax assets related to available-for-sale securities in combination with the entity's other deferred tax assets, among other changes. The Company is required to adopt this standard starting in the first quarter of fiscal year 2019 and does not anticipate that implementation will have a material impact on its Condensed Consolidated Financial Statements. In January 2016, FASB released ASU 2016-2, "Leases." The amendment requires an entity to recognize right-of-use assets and lease liabilities on its balance sheet and disclose key information about leasing arrangements. The amendment offers specific accounting guidance for a lessee, a lessor and sale and leaseback transactions. Lessees and lessors are required to disclose qualitative and quantitative information about leasing arrangements to enable a user of the financial statements to assess the amount, timing and uncertainty of cash flows arising from leases. The Company is required to adopt this standard starting in the first quarter of fiscal year 2020. Early adoption is permitted. The Company is currently in the process of evaluating the impact of adoption on its Condensed Consolidated Financial Statements. In March 2016, FASB released ASU 2016-9, "Compensation - Stock Compensation." Key changes in the amendment include: • entities will be required to recognize all excess tax benefits or deficiencies as an income tax benefit or expense in the income statement, eliminating APIC pools; • entities will no longer be required to delay recognition of excess tax benefits until they are realized; • entities will be required to classify the excess tax benefits as an operating activity in the statement of cash flows; • entities will be allowed to elect an accounting policy to either estimate the number of forfeitures, or account for forfeitures as they occur; and • entities can withhold up to the maximum individual statutory tax rate without classifying the awards as a liability, the cash paid to satisfy the statutory income tax withholding obligations shall be classified as a financing activity in the statement of cash flows. The Company is required to adopt this standard starting in the first quarter of fiscal year 2018. The Company is currently in the process of evaluating the impact of adoption on its Condensed Consolidated Financial Statements. In June 2016, FASB released ASU 2016-13, "Financial Instruments - Credit Losses." The amendment revises the impairment model to utilize an expected loss methodology in place of the currently used incurred loss methodology, which will result in more timely recognition of losses on financial instruments, including, but not limited to, available for sale debt securities and accounts receivable. The Company is required to adopt this standard starting in the first quarter of fiscal year 2021. Early adoption is permitted. The Company is currently in the process of evaluating the impact of adoption on its Condensed Consolidated Financial Statements.
Inventories	Inventories are stated at the lower of cost (first-in, first-out method) or market. System shipments to Japanese customers, for which title does not transfer until customer acceptance, are classified as finished goods inventory and carried at cost until title transfers.
Warranties	The Company provides standard warranties on its systems. The liability amount is based on actual historical warranty spending activity by type of system, customer, and geographic region, modified for any known differences such as the impact of system reliability improvements.

EQUITY-BASED COMPENSATION PLA23

EQUITY-BASED COMPENSATION PLANS (Tables)	3 Months Ended
	Sep. 25, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Recognized Equity Based Compensation Expense and Related Income Tax Benefit	The Company recognized the following equity-based compensation expense and related income tax benefit in the Condensed Consolidated Statements of Operations: Three Months Ended September 25, September 27, (in thousands) Equity-based compensation expense $ 38,595 $ 35,774 Income tax benefit recognized related to equity-based compensation expense $ 10,905 $ 6,097
Summary of Stock Plan Activity	A summary of stock plan transactions is as follows: Options Outstanding Restricted Stock Units Outstanding Number of Weighted- Number of Weighted- June 26, 2016 907,411 $ 47.41 4,335,104 $ 69.30 Granted — $ — 34,458 $ 87.59 Exercised (54,364 ) $ 32.29 N/A N/A Canceled — $ — (50,640 ) $ 67.67 Vested restricted stock N/A N/A (61,540 ) $ 65.09 September 25, 2016 853,047 $ 48.37 4,257,382 $ 69.51
Schedule of ESPP Weighted-Average Assumptions	Purchase rights under the 1999 ESPP were valued using the Black-Scholes option valuation model and the following weighted-average assumptions for the three months ended September 25, 2016 and September 27, 2015 : Three Months Ended September 25, September 27, Expected term (years) 0.77 0.68 Expected stock price volatility 33.02 % 31.56 % Risk-free interest rate 0.43 % 0.18 % Dividend Yield 1.14 % 0.93 %

OTHER EXPENSE, NET (Tables)

OTHER EXPENSE, NET (Tables)	3 Months Ended
	Sep. 25, 2016
Other Income and Expenses [Abstract]
Components of Other Expense, Net	The significant components of other expense, net, are as follows: Three Months Ended September 25, September 27, (in thousands) Interest income $ 12,763 $ 5,760 Interest expense (41,429 ) (24,661 ) Gains (losses) on deferred compensation plan related assets, net 6,172 (5,164 ) Foreign exchange gains (losses), net 1,219 (698 ) Other, net (1,879 ) (2,358 ) $ (23,154 ) $ (27,121 )

NET INCOME PER SHARE (Tables)

NET INCOME PER SHARE (Tables)	3 Months Ended
	Sep. 25, 2016
Earnings Per Share [Abstract]
Schedule of Numerators and Denominators of Basic and Diluted Computations for Net Income Per Share	The following table reconciles the numerators and denominators of the basic and diluted computations for net income per share. Three Months Ended September 25, September 27, (in thousands, except per share data) Numerator: Net income $ 263,835 $ 288,679 Denominator: Basic average shares outstanding 160,607 158,352 Effect of potential dilutive securities: Employee stock plans 2,142 2,544 Convertible notes 15,220 13,120 Warrants 2,048 358 Diluted average shares outstanding 180,017 174,374 Net income per share - basic $ 1.64 $ 1.82 Net income per share - diluted $ 1.47 $ 1.66
Schedule of Potentially Dilutive Securities Excluded from EPS Calculations	The following potentially dilutive securities were excluded: Three Months Ended September 25, September 27, (in thousands) Number of options and RSUs excluded 196 93

FINANCIAL INSTRUMENTS (Tables)

FINANCIAL INSTRUMENTS (Tables)	3 Months Ended
	Sep. 25, 2016
Fair Value Disclosures [Abstract]
Cash, Cash Equivalents, Investments, Restricted Cash and Investments and Other Assets Measured at Fair Value on Recurring Basis	The following table sets forth the Company’s cash, cash equivalents, investments, restricted cash and investments, and other assets measured at fair value on a recurring basis as of September 25, 2016 and June 26, 2016 : September 25, 2016 (Reported Within) Cost Unrealized Unrealized Fair Value Cash and Investments Restricted Other (in thousands) Cash $ 768,071 $ — $ — $ 768,071 $ 762,458 $ — $ 5,613 $ — Level 1: Time Deposit 913,725 — — 913,725 663,698 — 250,027 — Money Market Funds 4,180,031 — — 4,180,031 4,180,031 — — — U.S. Treasury and Agencies 366,017 951 (3 ) 366,965 86,092 280,873 — — Mutual Funds 39,010 1,773 (195 ) 40,588 — — — 40,588 Level 1 Total 5,498,783 2,724 (198 ) 5,501,309 4,929,821 280,873 250,027 40,588 Level 2: Municipal Notes and Bonds 201,502 183 (76 ) 201,609 — 201,609 — — Government-Sponsored Enterprises 31,701 49 (14 ) 31,736 — 31,736 — — Foreign Government Bonds 14,357 20 (1 ) 14,376 — 14,376 — — Corporate Notes and Bonds 937,712 2,871 (201 ) 940,382 169,422 770,960 — — Mortgage Backed Securities — Residential 15,747 53 (141 ) 15,659 — 15,659 — — Mortgage Backed Securities — Commercial 37,661 18 (117 ) 37,562 — 37,562 — — Level 2 Total 1,238,680 3,194 (550 ) 1,241,324 169,422 1,071,902 — — Total $ 7,505,534 $ 5,918 $ (748 ) $ 7,510,704 $ 5,861,701 $ 1,352,775 $ 255,640 $ 40,588 June 26, 2016 (Reported Within) Cost Unrealized Unrealized Fair Value Cash and Investments Restricted Other (in thousands) Cash $ 418,216 $ — $ — $ 418,216 $ 412,573 $ — $ 5,643 $ — Level 1: Time Deposit 904,243 — — 904,243 659,465 — 244,778 — Money Market Funds 3,904,288 — — 3,904,288 3,904,288 — — — U.S. Treasury and Agencies 446,530 2,041 (2 ) 448,569 62,996 385,573 — — Mutual Funds 39,318 1,400 (397 ) 40,321 — — — 40,321 Level 1 Total 5,294,379 3,441 (399 ) 5,297,421 4,626,749 385,573 244,778 40,321 Level 2: Municipal Notes and Bonds 265,386 355 (16 ) 265,725 — 265,725 — — U.S. Treasury and Agencies 8,068 151 — 8,219 — 8,219 — — Government-Sponsored Enterprises 31,885 91 (13 ) 31,963 — 31,963 — — Foreign Government Bonds 41,440 76 (4 ) 41,512 — 41,512 — — Corporate Notes and Bonds 979,566 4,341 (566 ) 983,341 — 983,341 — — Mortgage Backed Securities — Residential 17,395 37 (152 ) 17,280 — 17,280 — — Mortgage Backed Securities — Commercial 55,129 30 (160 ) 54,999 — 54,999 — — Level 2 Total 1,398,869 5,081 (911 ) 1,403,039 — 1,403,039 — — Total $ 7,111,464 $ 8,522 $ (1,310 ) $ 7,118,676 $ 5,039,322 $ 1,788,612 $ 250,421 $ 40,321
Schedule of Cash, Cash Equivalents, Investments and Restricted Cash and Investments in Unrealized Loss Positions	The following is an analysis of the Company’s cash, cash equivalents, investments, and restricted cash and investments in unrealized loss positions: September 25, 2016 Unrealized Losses Unrealized Losses Total Fair Value Gross Fair Value Gross Fair Value Gross (in thousands) Municipal Notes and Bonds $ 110,401 $ (71 ) $ 1,995 $ (5 ) $ 112,396 $ (76 ) U.S. Treasury & Agencies 8,247 (3 ) — — 8,247 (3 ) Mutual Funds — — 8,964 (195 ) 8,964 (195 ) Government-Sponsored Enterprises 419 — 621 (14 ) 1,040 (14 ) Foreign Government Bonds 4,250 (1 ) — — 4,250 (1 ) Corporate Notes and Bonds 147,348 (83 ) 47,805 (118 ) 195,153 (201 ) Mortgage Backed Securities — Residential 8,469 (57 ) 3,897 (84 ) 12,366 (141 ) Mortgage Backed Securities — Commercial 28,585 (82 ) 6,318 (35 ) 34,903 (117 ) $ 307,719 $ (297 ) $ 69,600 $ (451 ) $ 377,319 $ (748 )
Schedule of Amortized Cost and Fair Value of Cash Equivalents, Investments, Restricted Cash and Investments with Contractual Maturities	The amortized cost and fair value of cash equivalents, investments and restricted investments with contractual maturities are as follows as of September 25, 2016 : Cost Estimated (in thousands) Due in one year or less $ 5,898,756 $ 5,898,959 Due after one year through five years 730,005 733,625 Due in more than five years 69,692 69,461 $ 6,698,453 $ 6,702,045
Schedule of Outstanding Foreign Currency Forward Contracts	As of September 25, 2016 , the Company had the following outstanding foreign currency contracts that were entered into under its cash flow and balance sheet hedge program: Notional Value Derivatives Designated as Derivatives Not Designated (in thousands) Foreign Currency Forward Contracts Buy Contracts Sell Contracts Buy Contracts Sell Contracts Japanese yen $ — $ 104,039 $ — $ 181,405 Swiss franc — — 7,387 — Euro 24,049 — 31,518 — Korean won 5,740 — 9,402 — Chinese renminbi — — 8,215 Singapore dollar — — 33,867 — Taiwan dollar — — 22,790 — $ 29,789 $ 104,039 $ 113,179 $ 181,405 Foreign Currency Option Contracts Buy Put Sell Put Buy Put (1) Sell Put Japanese yen $ — $ — $ 15,695 $ 15,695 (1) Contracts were entered into and designated as cash flow hedges under ASC 815, contracts were subsequently de-designated, changes in fair market value subsequent to de-designation effect current earnings.
Schedule of Fair Value of Derivatives Instruments	The fair value of derivative instruments in the Company’s Condensed Consolidated Balance Sheets as of September 25, 2016 and June 26, 2016 were as follows: September 25, 2016 June 26, 2016 Fair Value of Derivative Instruments (Level 2) Fair Value of Derivative Instruments (Level 2) Asset Derivatives Liability Derivatives Asset Derivatives Liability Derivatives Balance Sheet Fair Value Balance Sheet Fair Value Balance Sheet Fair Value Balance Sheet Fair Value (in thousands) Derivatives designated as hedging instruments: Foreign exchange forward contracts Prepaid expense $ 113 Accrued liabilities $ 5,734 Prepaid expense $ 249 Accrued liabilities $ 16,585 Interest rate contracts, short-term Accrued expenses and other current liabilities 2,623 Prepaid expense — Accrued expenses and other current liabilities 50 Prepaid expense 159 Interest rate contracts, long-term Other assets 4,968 Other long-term liabilities — Other assets 8,661 Other long-term liabilities — Derivatives not designated as hedging instruments: Foreign exchange forward contracts Prepaid expense 279 Accrued 83 Prepaid expense 107 Accrued 1,529 Total derivatives $ 7,983 $ 5,817 $ 9,067 $ 18,273
Schedule of Derivative Instruments Designated as Cash Flow Hedges in Statements of Operations	The effect of derivative instruments designated as cash flow hedges on the Company’s Condensed Consolidated Statements of Operations, including accumulated other comprehensive income (“AOCI”) was as follows: Three Months Ended September 25, 2016 Three Months Ended September 27, 2015 Effective Portion Ineffective Effective Portion Ineffective Location of Gain (Loss) Gain (Loss) Gain (Loss) Loss Gain (Loss) Gain (Loss) Derivatives Designated (in thousands) Foreign Exchange Contracts Revenue $ (2,913 ) $ (13,605 ) $ 705 $ (69 ) $ (1,378 ) $ 32 Foreign Exchange Contracts Cost of goods sold 235 173 (67 ) (415 ) 1,505 (22 ) Foreign Exchange Contracts Selling, general, and (24 ) (9 ) (21 ) (173 ) 258 (7 ) Interest Rate Contracts Other expense, net — 9 — — (94 ) — $ (2,702 ) $ (13,432 ) $ 617 $ (657 ) $ 291 $ 3 The effect of derivative instruments not designated as cash flow hedges on the Company’s Condensed Consolidated Statements of Operations was as follows: Three Months Ended September 25, 2016 September 27, 2015 Derivatives Not Designated as Hedging Instruments: Location Loss Recognized Gain (in thousands) Foreign Exchange Contracts Other $ (383 ) $ 6,007

INVENTORIES (Tables)

INVENTORIES (Tables)	3 Months Ended
	Sep. 25, 2016
Inventory Disclosure [Abstract]
Schedule of Inventories	Inventories consist of the following: September 25, June 26, (in thousands) Raw materials $ 549,406 $ 536,844 Work-in-process 139,120 151,406 Finished goods 243,055 283,661 $ 931,581 $ 971,911

GOODWILL AND INTANGIBLE ASSETS

GOODWILL AND INTANGIBLE ASSETS (Tables)	3 Months Ended
	Sep. 25, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets	The following table provides the Company’s intangible assets as of September 25, 2016 : Gross Accumulated Net (in thousands) Customer relationships $ 615,193 $ (317,130 ) $ 298,063 Existing technology 643,261 (422,518 ) 220,743 Patents 36,553 (29,335 ) 7,218 Other intangible assets 36,114 (35,545 ) 569 Total intangible assets $ 1,331,121 $ (804,528 ) $ 526,593 The following table provides the Company’s intangible assets as of June 26, 2016 : Gross Accumulated Net (in thousands) Customer relationships $ 615,272 $ (300,711 ) $ 314,561 Existing technology 643,433 (401,036 ) 242,397 Patents 36,053 (28,701 ) 7,352 Other intangible assets 36,114 (35,503 ) 611 Total intangible assets $ 1,330,872 $ (765,951 ) $ 564,921
Estimated Future Amortization Expense of Intangible Assets	The estimated future amortization expense of intangible assets, excluding those with indefinite lives, as of September 25, 2016 was as follows: Fiscal Year Amount (in thousands) 2017 (remaining 9 months) $ 116,002 2018 153,337 2019 115,263 2020 50,194 2021 47,792 Thereafter 44,005 $ 526,593

ACCRUED EXPENSES AND OTHER CU29

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables)	3 Months Ended
	Sep. 25, 2016
Payables and Accruals [Abstract]
Schedule of Accrued Expenses and Other Current Liabilities	Accrued expenses and other current liabilities consist of the following: September 25, June 26, (in thousands) Accrued compensation $ 357,134 $ 331,528 Warranty reserves 103,226 100,321 Income and other taxes payable 68,057 86,723 Dividend payable 48,397 48,052 Other 188,841 206,286 $ 765,655 $ 772,910

LONG-TERM DEBT AND OTHER BORR30

LONG-TERM DEBT AND OTHER BORROWINGS (Tables)	3 Months Ended
	Sep. 25, 2016
Debt Disclosure [Abstract]
Schedule of Outstanding Debt	As of September 25, 2016 and June 26, 2016 , the Company's outstanding debt consisted of the following: September 25, 2016 June 26, 2016 Amount (in thousands) Effective Interest Rate Amount (in thousands) Effective Interest Rate Fixed-rate 1.25% Convertible Notes Due May 15, 2018 ("2018 Notes") $ 449,947 (1) 5.27 % $ 449,954 (3) 5.27 % Fixed-rate 2.75% Senior Notes Due March 15, 2020 ("2020 Notes") 500,000 2.88 % 500,000 2.88 % Fixed-rate 2.80% Senior Notes Due June 15, 2021 ("2021 Notes") 800,000 2.95 % 800,000 2.95 % Fixed-rate 3.45% Senior Notes Due June 15, 2023 ("2023 Notes") 600,000 3.60 % 600,000 3.60 % Fixed-rate 3.80% Senior Notes Due March 15, 2025 ("2025 Notes") 500,000 3.87 % 500,000 3.87 % Fixed-rate 3.90% Senior Notes Due June 15, 2026 ("2026 Notes") 1,000,000 4.01 % 1,000,000 4.01 % Fixed-rate 2.625% Convertible Notes Due May 15, 2041 ("2041 Notes") 699,883 (1) 4.28 % 699,895 (3) 4.28 % Total debt outstanding, at par 4,549,830 4,549,849 Unamortized discount (226,811 ) (232,727 ) Fair value adjustment - interest rate contracts 7,592 8,552 Unamortized bond issuance costs (6,781 ) (7,213 ) (4) Total debt outstanding, at carrying value $ 4,323,830 $ 4,318,461 Reported as: Current portion of long-term debt $ 945,836 (2) $ 940,537 (2) Long-term debt 3,377,994 3,377,924 Total debt outstanding, at carrying value $ 4,323,830 $ 4,318,461 ____________________________ (1) As of September 25, 2016 , these notes were convertible at the option of the bondholder, as a result of the condition described in (2) below. Upon closure of the conversion period, Notes not converted will be reclassified back into noncurrent liabilities and the temporary equity will be reclassified into permanent equity. (2) As of the report date the market value of the Company's Common Stock was greater than 130% of the convertible notes conversion price for 20 or more of the 30 consecutive trading days preceding the quarter-end. As a result, the convertible notes were classified in current liabilities and a portion of the equity component, representing the unamortized discount, was classified in temporary equity on the Company's Consolidated Balance Sheets. (3) As of June 26, 2016 , these notes were convertible at the option of the bond holder, as a result of the condition described in (2) above. (4) The Company adopted ASU 2015-3, regarding the simplification of the presentation of bond issuance costs, which requires that bond issuance costs related to a recognized liability be presented on the balance sheet as a direct reduction from the carrying amount of that debt liability, consistent with debt discounts. The Company applied the accounting standard update on a retrospective basis by reclassifying the presentation of bond issuance costs totaling $1.76 million which was originally included in prepaid assets and other current assets against current portion of convertible notes and capital leases, and $5.45 million which was originally included in other assets against senior notes, convertible notes, and capital leases, less current portion on the Condensed Consolidated Balance Sheets for June 26, 2016 . There is no impact to the Company's Condensed Consolidated Statements of Operation, Stockholders' Equity, or Cash Flows for the fiscal year ended June 26, 2016 .
Components of Convertible Notes	Selected additional information regarding the Convertible Notes outstanding as of September 25, 2016 and June 26, 2016 , the Convertible Notes consisted of the following: September 25, 2016 June 26, 2016 2018 Notes 2041 Notes 2018 Notes 2041 Notes (in thousands, except years, percentages, conversion rate, and conversion price) Carrying amount of permanent equity component, net of tax $ 77,064 $153,384 $ 72,992 $ 152,397 Carrying amount of temporary equity component, net of tax $ 27,818 $ 174,649 $ 31,894 $ 175,658 Remaining amortization period (years) 1.6 24.6 1.9 24.9 Fair Value of Notes (Level 2) $ 701,242 $ 1,906,194 Conversion rate (shares of common stock per $1,000 principal amount of notes) 16.3893 29.4126 Conversion price (per share of common stock) $ 61.02 $ 34.00 If-converted value in excess of par value $ 226,868 $ 1,189,443 Estimated share dilution using average quarterly stock price $90.25 per share 2,389 12,830
Warrants and Convertible Note Hedge Arrangements	The following table presents the details of the warrants and convertible note hedge arrangements as of September 25, 2016 : 2016 Notes 2018 Notes (shares in thousands) Warrants: Underlying shares 3,098 7,375 Estimated share dilution using average quarterly stock price $90.25 per share 694 1,354 Exercise price $ 69.07 $ 73.68 Expiration date range August 15 - October 21, 2016 August 15 - October 23, 2018 Convertible Note Hedge: Number of shares available from counterparties — 7,374 Exercise price $ — $ 61.02
Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]	Selected additional information regarding the Senior Notes outstanding as of September 25, 2016 is as follows: Remaining Amortization period Fair Value of Notes (Level 2) (years) (in thousands) 2020 Notes 3.4 $ 501,375 2021 Notes 4.7 $ 821,224 2023 Notes * $ 615,000 2025 Notes 8.4 $ 514,100 2026 Notes * $ 1,046,340 * As a result of the October 5, 2016 termination of the Agreement and Plan of Merger and Reorganization with KLA-Tencor (see Note 15 for additional information), the 2023 Notes and the 2026 Notes were redeemed on October 13, 2016 under the Special Mandatory Redemption terms of the indenture governing these Notes.
Schedule of Recognized Interest Cost Relating to Both Contractual Interest Coupon and Amortization of Discount on Liability Component of Notes	The following table presents the amount of interest cost recognized relating to both the contractual interest coupon and amortization of the debt discount, issuance costs, and effective portion of interest rate contracts with respect to the Convertible Notes, the Senior Notes, the term loan agreement and the revolving credit facility during the three months ended September 25, 2016 and September 27, 2015 . Three Months Ended September 25, September 27, (in thousands) Contractual interest coupon $ 34,712 $ 14,451 Amortization of interest discount 5,914 9,122 Amortization of issuance costs 918 652 Effect of interest rate contracts, net (1,058 ) 94 Total interest cost recognized $ 40,486 $ 24,319

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Tables)	3 Months Ended
	Sep. 25, 2016
Commitments and Contingencies Disclosure [Abstract]
Warranties	Changes in the Company’s product warranty reserves were as follows: Three Months Ended September 25, September 27, (in thousands) Balance at beginning of period $ 100,321 $ 93,209 Warranties issued during the period 34,855 34,203 Settlements made during the period (32,228 ) (28,458 ) Changes in liability for pre-existing warranties 278 14 Balance at end of period $ 103,226 $ 98,968

ACCUMULATED OTHER COMPREHENSI32

ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)	3 Months Ended
	Sep. 25, 2016
Equity [Abstract]
Components of Accumulated Other Comprehensive Income (Loss)	The components of accumulated other comprehensive income (loss) (“AOCI”), net of tax at the end of the period, as well as the activity during the period, were as follows: Accumulated foreign Accumulated Accumulated Accumulated Total (in thousands) Balance as of June 26, 2016 $ (39,528 ) $ (15,623 ) $ 4,896 $ (19,078 ) $ (69,333 ) Other comprehensive income (loss) before reclassifications 4,302 (2,421 ) (2,723 ) 123 (719 ) Losses reclassified from accumulated other comprehensive income (loss) to net income 199 (2) 11,950 (1) 903 (2) — 13,052 Net current-period other comprehensive income (loss) $ 4,501 $ 9,529 $ (1,820 ) $ 123 $ 12,333 Balance as of September 25, 2016 $ (35,027 ) $ (6,094 ) $ 3,076 $ (18,955 ) $ (57,000 ) (1) Amount of after tax gain reclassified from AOCI into net income located in revenue: $12,094 loss; cost of goods sold: $147 gain; selling, general and administrative expenses: $9 loss; and other income and expense: $6 gain. (2) Amount of after tax gain reclassified from accumulated other comprehensive income into net income located in other expense, net.

EQUITY-BASED COMPENSATION PLA33

EQUITY-BASED COMPENSATION PLANS - Additional Information (Detail) $ in Millions	3 Months Ended
	Sep. 25, 2016USD ($)period
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options and restricted stock units vesting period (years)	3 years
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation expense, stock option	$ 4.1
Weighted average remaining period for recognition (years)	2 years 1 month 28 days
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average remaining period for recognition (years)	2 years
Unrecognized compensation expense	$ 187.4
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average remaining period for recognition (years)	1 year 28 days
ESPP purchase price per share as percentage of fair market value	85.00%
Offering period	14 months
Interim purchase periods | period	3
Unrecognized compensation expense	$ 19

EQUITY-BASED COMPENSATION PLA34

EQUITY-BASED COMPENSATION PLANS - Recognized Equity Based Compensation Expenses and Related Income Tax Benefit (Detail) - USD ($) $ in Thousands	3 Months Ended
	Sep. 25, 2016	Sep. 27, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Equity-based compensation expense	$ 38,595	$ 35,774
Income tax benefit recognized related to equity-based compensation expense	$ 10,905	$ 6,097

EQUITY-BASED COMPENSATION PLA35

EQUITY-BASED COMPENSATION PLANS - Summary of Stock Plan Activity (Detail)	3 Months Ended
	Sep. 25, 2016$ / sharesshares
Options outstanding, number of shares
Beginning balance (in shares) | shares	907,411
Granted (in shares) | shares	0
Exercised (in shares) | shares	(54,364)
Canceled (in shares) | shares	0
Ending balance (in shares) | shares	853,047
Options outstanding, weighted-average exercise price
Beginning balance (in dollars per share) | $ / shares	$ 47.41
Granted (in dollars per share) | $ / shares	0
Exercised (in dollars per share) | $ / shares	32.29
Canceled (in dollars per share) | $ / shares	0
Ending balance (in dollars per share) | $ / shares	$ 48.37
Restricted stock units outstanding, number of shares
Beginning balance (in shares) | shares	4,335,104
Granted (in shares) | shares	34,458
Canceled (in shares) | shares	(50,640)
Vested restricted stock (in shares) | shares	(61,540)
Ending balance (in shares) | shares	4,257,382
Restricted stock units outstanding, weighted-average fair market value at grant
Beginning balance (in dollars per share) | $ / shares	$ 69.30
Granted (in dollars per share) | $ / shares	87.59
Canceled (in dollars per share) | $ / shares	67.67
Vested restricted stock (in dollars per share) | $ / shares	65.09
Ending balance (in dollars per share) | $ / shares	$ 69.51

EQUITY-BASED COMPENSATION PLA36

EQUITY-BASED COMPENSATION PLANS - Schedule of ESPP Weighted-Average Assumptions (Detail) - Employee Stock Purchase Plan	3 Months Ended
	Sep. 25, 2016	Sep. 27, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (years)	9 months 7 days	8 months 5 days
Expected stock price volatility (percentage)	33.02%	31.56%
Risk-free interest rate (percentage)	0.43%	0.18%
Dividend yield (percentage)	1.14%	0.93%

OTHER EXPENSE, NET (Detail)

OTHER EXPENSE, NET (Detail) - USD ($)	3 Months Ended
	Sep. 25, 2016	Sep. 27, 2015	Jun. 26, 2016
Other Income and Expenses [Abstract]
Interest income	$ 12,763,000	$ 5,760,000
Interest expense	(41,429,000)	(24,661,000)
Gains (losses) on deferred compensation plan related assets, net	6,172,000	(5,164,000)
Foreign exchange gains (losses), net	1,219,000	(698,000)
Other, net	(1,879,000)	(2,358,000)
Other income (expense), net	$ (23,154,000)	$ (27,121,000)
Senior Note
Debt Instrument [Line Items]
Principal amount			$ 2,400,000,000

INCOME TAX EXPENSE (Detail)

INCOME TAX EXPENSE (Detail) - USD ($) $ in Thousands	3 Months Ended
	Sep. 25, 2016	Sep. 27, 2015
Income Tax Disclosure [Abstract]
Income tax expense	$ 28,958	$ 19,628
Effective income tax rate (percentage)	9.90%
U.S. federal statutory tax rate (percentage)	35.00%

NET INCOME PER SHARE - Schedule

NET INCOME PER SHARE - Schedule of Numerators and Denominators of Basic and Diluted Computations for Net Income Per Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Sep. 25, 2016	Sep. 27, 2015
Numerator:
Net income	$ 263,835	$ 288,679
Denominator:
Basic average shares outstanding	160,607	158,352
Effect of potential dilutive securities:
Employee stock plans	2,142	2,544
Convertible notes	15,220	13,120
Warrants	2,048	358
Diluted average shares outstanding	180,017	174,374
Net income per share - basic (in dollars per share)	$ 1.64	$ 1.82
Net income per share - diluted (in dollars per share)	$ 1.47	$ 1.66

NET INCOME PER SHARE - Schedu40

NET INCOME PER SHARE - Schedule of Potentially Dilutive Securities Excluded from EPS Calculations (Detail) - shares shares in Thousands	3 Months Ended
	Sep. 25, 2016	Sep. 27, 2015
Earnings Per Share [Abstract]
Number of options and RSUs excluded (in shares)	196	93

FINANCIAL INSTRUMENTS - Cash, C

FINANCIAL INSTRUMENTS - Cash, Cash Equivalents, Investments, Restricted Cash and Investments and Other Assets Measured at Fair Value on Recurring Basis (Detail) - USD ($)	3 Months Ended
	Sep. 25, 2016	Sep. 27, 2015	Jun. 26, 2016
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cost	$ 7,505,534,000		$ 7,111,464,000
Unrealized Gain	5,918,000		8,522,000
Unrealized (Loss)	(748,000)		(1,310,000)
Fair Value	7,510,704,000		7,118,676,000
Cash and Cash Equivalents	5,861,701,000		5,039,322,000
Investments	1,352,775,000		1,788,612,000
Restricted Cash & Investments	255,640,000		250,421,000
Other Assets	40,588,000		40,321,000
Other than temporary impairment included in net realized gains (losses)	0	$ 0
Gross realized gains from sale of investments	2,600,000	200,000
Gross realized losses from sale of investments	200,000	$ 700,000
Fair Value Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cost	5,498,783,000		5,294,379,000
Unrealized Gain	2,724,000		3,441,000
Unrealized (Loss)	(198,000)		(399,000)
Fair Value	5,501,309,000		5,297,421,000
Cash and Cash Equivalents	4,929,821,000		4,626,749,000
Investments	280,873,000		385,573,000
Restricted Cash & Investments	250,027,000		244,778,000
Other Assets	40,588,000		40,321,000
Fair Value of Derivative Instruments (Level 2)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cost	1,238,680,000		1,398,869,000
Unrealized Gain	3,194,000		5,081,000
Unrealized (Loss)	(550,000)		(911,000)
Fair Value	1,241,324,000		1,403,039,000
Cash and Cash Equivalents	169,422,000		0
Investments	1,071,902,000		1,403,039,000
Restricted Cash & Investments	0		0
Other Assets	0		0
Cash
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cost	768,071,000		418,216,000
Unrealized Gain	0		0
Unrealized (Loss)	0		0
Fair Value	768,071,000		418,216,000
Cash and Cash Equivalents	762,458,000		412,573,000
Investments	0		0
Restricted Cash & Investments	5,613,000		5,643,000
Other Assets	0		0
Time Deposit | Fair Value Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cost	913,725,000		904,243,000
Unrealized Gain	0		0
Unrealized (Loss)	0		0
Fair Value	913,725,000		904,243,000
Cash and Cash Equivalents	663,698,000		659,465,000
Investments	0		0
Restricted Cash & Investments	250,027,000		244,778,000
Other Assets	0		0
Money Market Funds | Fair Value Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cost	4,180,031,000		3,904,288,000
Unrealized Gain	0		0
Unrealized (Loss)	0		0
Fair Value	4,180,031,000		3,904,288,000
Cash and Cash Equivalents	4,180,031,000		3,904,288,000
Investments	0		0
Restricted Cash & Investments	0		0
Other Assets	0		0
U.S. Treasury and Agencies | Fair Value Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cost	366,017,000		446,530,000
Unrealized Gain	951,000		2,041,000
Unrealized (Loss)	(3,000)		(2,000)
Fair Value	366,965,000		448,569,000
Cash and Cash Equivalents	86,092,000		62,996,000
Investments	280,873,000		385,573,000
Restricted Cash & Investments	0		0
Other Assets	0		0
U.S. Treasury and Agencies | Fair Value of Derivative Instruments (Level 2)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cost			8,068,000
Unrealized Gain			151,000
Unrealized (Loss)			0
Fair Value			8,219,000
Cash and Cash Equivalents			0
Investments			8,219,000
Restricted Cash & Investments			0
Other Assets			0
Mutual Funds | Fair Value Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cost	39,010,000		39,318,000
Unrealized Gain	1,773,000		1,400,000
Unrealized (Loss)	(195,000)		(397,000)
Fair Value	40,588,000		40,321,000
Cash and Cash Equivalents	0		0
Investments	0		0
Restricted Cash & Investments	0		0
Other Assets	40,588,000		40,321,000
Municipal Notes and Bonds | Fair Value of Derivative Instruments (Level 2)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cost	201,502,000		265,386,000
Unrealized Gain	183,000		355,000
Unrealized (Loss)	(76,000)		(16,000)
Fair Value	201,609,000		265,725,000
Cash and Cash Equivalents	0		0
Investments	201,609,000		265,725,000
Restricted Cash & Investments	0		0
Other Assets	0		0
Government-Sponsored Enterprises | Fair Value of Derivative Instruments (Level 2)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cost	31,701,000		31,885,000
Unrealized Gain	49,000		91,000
Unrealized (Loss)	(14,000)		(13,000)
Fair Value	31,736,000		31,963,000
Cash and Cash Equivalents	0		0
Investments	31,736,000		31,963,000
Restricted Cash & Investments	0		0
Other Assets	0		0
Foreign Government Bonds | Fair Value of Derivative Instruments (Level 2)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cost	14,357,000		41,440,000
Unrealized Gain	20,000		76,000
Unrealized (Loss)	(1,000)		(4,000)
Fair Value	14,376,000		41,512,000
Cash and Cash Equivalents	0		0
Investments	14,376,000		41,512,000
Restricted Cash & Investments	0		0
Other Assets	0		0
Corporate Notes and Bonds | Fair Value of Derivative Instruments (Level 2)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cost	937,712,000		979,566,000
Unrealized Gain	2,871,000		4,341,000
Unrealized (Loss)	(201,000)		(566,000)
Fair Value	940,382,000		983,341,000
Cash and Cash Equivalents	169,422,000		0
Investments	770,960,000		983,341,000
Restricted Cash & Investments	0		0
Other Assets	0		0
Mortgage Backed Securities — Residential | Fair Value of Derivative Instruments (Level 2)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cost	15,747,000		17,395,000
Unrealized Gain	53,000		37,000
Unrealized (Loss)	(141,000)		(152,000)
Fair Value	15,659,000		17,280,000
Cash and Cash Equivalents	0		0
Investments	15,659,000		17,280,000
Restricted Cash & Investments	0		0
Other Assets	0		0
Mortgage Backed Securities — Commercial | Fair Value of Derivative Instruments (Level 2)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cost	37,661,000		55,129,000
Unrealized Gain	18,000		30,000
Unrealized (Loss)	(117,000)		(160,000)
Fair Value	37,562,000		54,999,000
Cash and Cash Equivalents	0		0
Investments	37,562,000		54,999,000
Restricted Cash & Investments	0		0
Other Assets	$ 0		$ 0

FINANCIAL INSTRUMENTS - Schedul

FINANCIAL INSTRUMENTS - Schedule of Cash, Cash Equivalents, Investments and Restricted Cash and Investments Unrealized Loss Positions (Detail) $ in Thousands	Sep. 25, 2016USD ($)
Fair Value
Unrealized Losses Less Than 12 Months	$ 307,719
Unrealized Losses 12 Months or Greater	69,600
Total	377,319
Unrealized Losses 12 Months or Greater
Unrealized Losses Less Than 12 Months	(297)
Unrealized Losses 12 Months or Greater	(451)
Total	(748)
Municipal Notes and Bonds
Fair Value
Unrealized Losses Less Than 12 Months	110,401
Unrealized Losses 12 Months or Greater	1,995
Total	112,396
Unrealized Losses 12 Months or Greater
Unrealized Losses Less Than 12 Months	(71)
Unrealized Losses 12 Months or Greater	(5)
Total	(76)
U.S. Treasury & Agencies
Fair Value
Unrealized Losses Less Than 12 Months	8,247
Unrealized Losses 12 Months or Greater	0
Total	8,247
Unrealized Losses 12 Months or Greater
Unrealized Losses Less Than 12 Months	(3)
Unrealized Losses 12 Months or Greater	0
Total	(3)
Mutual Funds
Fair Value
Unrealized Losses Less Than 12 Months	0
Unrealized Losses 12 Months or Greater	8,964
Total	8,964
Unrealized Losses 12 Months or Greater
Unrealized Losses Less Than 12 Months	0
Unrealized Losses 12 Months or Greater	(195)
Total	(195)
Government-Sponsored Enterprises
Fair Value
Unrealized Losses Less Than 12 Months	419
Unrealized Losses 12 Months or Greater	621
Total	1,040
Unrealized Losses 12 Months or Greater
Unrealized Losses Less Than 12 Months	0
Unrealized Losses 12 Months or Greater	(14)
Total	(14)
Foreign Government Bonds
Fair Value
Unrealized Losses Less Than 12 Months	4,250
Unrealized Losses 12 Months or Greater	0
Total	4,250
Unrealized Losses 12 Months or Greater
Unrealized Losses Less Than 12 Months	(1)
Unrealized Losses 12 Months or Greater	0
Total	(1)
Corporate Notes and Bonds
Fair Value
Unrealized Losses Less Than 12 Months	147,348
Unrealized Losses 12 Months or Greater	47,805
Total	195,153
Unrealized Losses 12 Months or Greater
Unrealized Losses Less Than 12 Months	(83)
Unrealized Losses 12 Months or Greater	(118)
Total	(201)
Mortgage Backed Securities — Residential
Fair Value
Unrealized Losses Less Than 12 Months	8,469
Unrealized Losses 12 Months or Greater	3,897
Total	12,366
Unrealized Losses 12 Months or Greater
Unrealized Losses Less Than 12 Months	(57)
Unrealized Losses 12 Months or Greater	(84)
Total	(141)
Mortgage Backed Securities — Commercial
Fair Value
Unrealized Losses Less Than 12 Months	28,585
Unrealized Losses 12 Months or Greater	6,318
Total	34,903
Unrealized Losses 12 Months or Greater
Unrealized Losses Less Than 12 Months	(82)
Unrealized Losses 12 Months or Greater	(35)
Total	$ (117)

FINANCIAL INSTRUMENTS - Sched43

FINANCIAL INSTRUMENTS - Schedule of Amortized Cost and Fair Value of Cash Equivalents, Investments, and Restricted Cash and Investments with Contractual Maturities (Detail) $ in Thousands	Sep. 25, 2016USD ($)
Cost
Due in one year or less	$ 5,898,756
Due after one year through five years	730,005
Due in more than five years	69,692
Total	6,698,453
Estimated Fair Value
Due in one year or less	5,898,959
Due after one year through five years	733,625
Due in more than five years	69,461
Total	$ 6,702,045

FINANCIAL INSTRUMENTS - Additio

FINANCIAL INSTRUMENTS - Additional Information (Detail) - USD ($)	3 Months Ended	12 Months Ended
	Sep. 25, 2016	Jun. 26, 2016	Jun. 28, 2015
Derivative Instruments, Gain (Loss) [Line Items]
Gain to be reclassified into earnings	$ 1,100,000
Foreign exchange forward contracts
Derivative Instruments, Gain (Loss) [Line Items]
Foreign exchange contracts amount of offset, assets	4,400,000	$ 6,400,000
Foreign exchange contracts amount of offset, liabilities	4,400,000	6,400,000
Net derivative asset from master netting agreements	3,600,000	$ 2,700,000
Net derivative liability from master netting agreements	1,400,000
Cash Flow Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Loss reclassification from AOCI to income, in the next 12 months	5,300,000
Losses accumulated in other comprehensive income expected to reclassify from other comprehensive income into earnings	$ 800,000
Gains (losses) accumulated in other comprehensive income expected to reclassify from other comprehensive income into earnings, estimate of time to transfer		9 years 8 months 15 days
Cash Flow Hedges | Forward-starting interest rate swap agreements
Derivative Instruments, Gain (Loss) [Line Items]
Derivative notional amount		$ 600,000,000	$ 375,000,000
Cash Flow Hedges | Foreign exchange forward contracts
Derivative Instruments, Gain (Loss) [Line Items]
Net derivative liability from master netting agreements		11,900,000
Cash Flow Hedges | Minimum
Derivative Instruments, Gain (Loss) [Line Items]
Foreign currency cash flow hedge, expiration period	12 months
Cash Flow Hedges | Maximum
Derivative Instruments, Gain (Loss) [Line Items]
Foreign currency cash flow hedge, expiration period	24 months
Fair Value Hedges | Interest rate contracts, short-term
Derivative Instruments, Gain (Loss) [Line Items]
Derivative notional amount		$ 400,000,000

FINANCIAL INSTRUMENTS - Sched45

FINANCIAL INSTRUMENTS - Schedule of Outstanding Foreign Currency Forward Contracts (Detail) - Foreign exchange forward contracts $ in Thousands	Sep. 25, 2016USD ($)
Foreign Currency Forward Contracts | Long | Derivatives Designated as Hedging Instruments
Derivative [Line Items]
Derivative notional amount	$ 29,789
Foreign Currency Forward Contracts | Long | Derivatives Designated as Hedging Instruments | Japanese yen
Derivative [Line Items]
Derivative notional amount	0
Foreign Currency Forward Contracts | Long | Derivatives Designated as Hedging Instruments | Swiss franc
Derivative [Line Items]
Derivative notional amount	0
Foreign Currency Forward Contracts | Long | Derivatives Designated as Hedging Instruments | Euro
Derivative [Line Items]
Derivative notional amount	24,049
Foreign Currency Forward Contracts | Long | Derivatives Designated as Hedging Instruments | Korean won
Derivative [Line Items]
Derivative notional amount	5,740
Foreign Currency Forward Contracts | Long | Derivatives Designated as Hedging Instruments | Chinese renminbi
Derivative [Line Items]
Derivative notional amount	0
Foreign Currency Forward Contracts | Long | Derivatives Designated as Hedging Instruments | Singapore dollar
Derivative [Line Items]
Derivative notional amount	0
Foreign Currency Forward Contracts | Long | Derivatives Designated as Hedging Instruments | Taiwan dollar
Derivative [Line Items]
Derivative notional amount	0
Foreign Currency Forward Contracts | Long | Derivatives Not Designated as Hedging Instruments
Derivative [Line Items]
Derivative notional amount	113,179
Foreign Currency Forward Contracts | Long | Derivatives Not Designated as Hedging Instruments | Japanese yen
Derivative [Line Items]
Derivative notional amount	0
Foreign Currency Forward Contracts | Long | Derivatives Not Designated as Hedging Instruments | Swiss franc
Derivative [Line Items]
Derivative notional amount	7,387
Foreign Currency Forward Contracts | Long | Derivatives Not Designated as Hedging Instruments | Euro
Derivative [Line Items]
Derivative notional amount	31,518
Foreign Currency Forward Contracts | Long | Derivatives Not Designated as Hedging Instruments | Korean won
Derivative [Line Items]
Derivative notional amount	9,402
Foreign Currency Forward Contracts | Long | Derivatives Not Designated as Hedging Instruments | Chinese renminbi
Derivative [Line Items]
Derivative notional amount	8,215
Foreign Currency Forward Contracts | Long | Derivatives Not Designated as Hedging Instruments | Singapore dollar
Derivative [Line Items]
Derivative notional amount	33,867
Foreign Currency Forward Contracts | Long | Derivatives Not Designated as Hedging Instruments | Taiwan dollar
Derivative [Line Items]
Derivative notional amount	22,790
Foreign Currency Forward Contracts | Short | Derivatives Designated as Hedging Instruments
Derivative [Line Items]
Derivative notional amount	104,039
Foreign Currency Forward Contracts | Short | Derivatives Designated as Hedging Instruments | Japanese yen
Derivative [Line Items]
Derivative notional amount	104,039
Foreign Currency Forward Contracts | Short | Derivatives Designated as Hedging Instruments | Swiss franc
Derivative [Line Items]
Derivative notional amount	0
Foreign Currency Forward Contracts | Short | Derivatives Designated as Hedging Instruments | Euro
Derivative [Line Items]
Derivative notional amount	0
Foreign Currency Forward Contracts | Short | Derivatives Designated as Hedging Instruments | Korean won
Derivative [Line Items]
Derivative notional amount	0
Foreign Currency Forward Contracts | Short | Derivatives Designated as Hedging Instruments | Chinese renminbi
Derivative [Line Items]
Derivative notional amount	0
Foreign Currency Forward Contracts | Short | Derivatives Designated as Hedging Instruments | Singapore dollar
Derivative [Line Items]
Derivative notional amount	0
Foreign Currency Forward Contracts | Short | Derivatives Designated as Hedging Instruments | Taiwan dollar
Derivative [Line Items]
Derivative notional amount	0
Foreign Currency Forward Contracts | Short | Derivatives Not Designated as Hedging Instruments
Derivative [Line Items]
Derivative notional amount	181,405
Foreign Currency Forward Contracts | Short | Derivatives Not Designated as Hedging Instruments | Japanese yen
Derivative [Line Items]
Derivative notional amount	181,405
Foreign Currency Forward Contracts | Short | Derivatives Not Designated as Hedging Instruments | Swiss franc
Derivative [Line Items]
Derivative notional amount	0
Foreign Currency Forward Contracts | Short | Derivatives Not Designated as Hedging Instruments | Euro
Derivative [Line Items]
Derivative notional amount	0
Foreign Currency Forward Contracts | Short | Derivatives Not Designated as Hedging Instruments | Korean won
Derivative [Line Items]
Derivative notional amount	0
Foreign Currency Forward Contracts | Short | Derivatives Not Designated as Hedging Instruments | Singapore dollar
Derivative [Line Items]
Derivative notional amount	0
Foreign Currency Forward Contracts | Short | Derivatives Not Designated as Hedging Instruments | Taiwan dollar
Derivative [Line Items]
Derivative notional amount	0
Foreign Currency Option Contracts | Long | Derivatives Designated as Hedging Instruments | Japanese yen
Derivative [Line Items]
Derivative notional amount	0
Foreign Currency Option Contracts | Long | Derivatives Not Designated as Hedging Instruments | Japanese yen
Derivative [Line Items]
Derivative notional amount	15,695
Foreign Currency Option Contracts | Short | Derivatives Designated as Hedging Instruments | Japanese yen
Derivative [Line Items]
Derivative notional amount	0
Foreign Currency Option Contracts | Short | Derivatives Not Designated as Hedging Instruments | Japanese yen
Derivative [Line Items]
Derivative notional amount	$ 15,695

FINANCIAL INSTRUMENTS - Sched46

FINANCIAL INSTRUMENTS - Schedule of Fair Value of Derivative Instruments (Detail) - Fair Value of Derivative Instruments (Level 2) - USD ($) $ in Thousands	Sep. 25, 2016	Jun. 26, 2016
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Asset Derivatives	$ 7,983	$ 9,067
Liability Derivatives	5,817	18,273
Derivatives Designated as Hedging Instruments | Prepaid expense and other assets | Foreign exchange forward contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Asset Derivatives	113	249
Derivatives Designated as Hedging Instruments | Prepaid expense and other assets | Interest rate contracts, short-term
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liability Derivatives	0	159
Derivatives Designated as Hedging Instruments | Other assets | Interest rate contracts, short-term
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Asset Derivatives	4,968	8,661
Derivatives Designated as Hedging Instruments | Accrued liabilities | Foreign exchange forward contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liability Derivatives	5,734	16,585
Derivatives Designated as Hedging Instruments | Accrued expenses and other current liabilities | Interest rate contracts, short-term
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Asset Derivatives	2,623	50
Derivatives Designated as Hedging Instruments | Other long-term liabilities | Interest rate contracts, short-term
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liability Derivatives	0	0
Derivatives Not Designated as Hedging Instruments | Prepaid expense and other assets | Foreign exchange forward contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Asset Derivatives	279	107
Derivatives Not Designated as Hedging Instruments | Accrued liabilities | Foreign exchange forward contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liability Derivatives	$ 83	$ 1,529

FINANCIAL INSTRUMENTS - Sched47

FINANCIAL INSTRUMENTS - Schedule of Derivative Instruments Designated as Cash Flow Hedges in Statements of Operations Including Accumulated Other Comprehensive Income (Detail) - USD ($) $ in Thousands	3 Months Ended
	Sep. 25, 2016	Sep. 27, 2015
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain (Loss) Recognized in AOCI (Effective Portion)	$ (2,702)	$ (657)
Gain (Loss) Reclassified from AOCI into Income (Effective Portion)	(13,432)	291
Gain (Loss) Recognized In Income (Excluded from Effectiveness)	617	3
Foreign Exchange Contracts | Revenue
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain (Loss) Recognized in AOCI (Effective Portion)	(2,913)	(69)
Gain (Loss) Reclassified from AOCI into Income (Effective Portion)	(13,605)	(1,378)
Gain (Loss) Recognized In Income (Excluded from Effectiveness)	705	32
Foreign Exchange Contracts | Cost of goods sold
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain (Loss) Recognized in AOCI (Effective Portion)	235	(415)
Gain (Loss) Reclassified from AOCI into Income (Effective Portion)	173	1,505
Gain (Loss) Recognized In Income (Excluded from Effectiveness)	(67)	(22)
Foreign Exchange Contracts | Selling, general, and administrative
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain (Loss) Recognized in AOCI (Effective Portion)	(24)	(173)
Gain (Loss) Reclassified from AOCI into Income (Effective Portion)	(9)	258
Gain (Loss) Recognized In Income (Excluded from Effectiveness)	(21)	(7)
Foreign Exchange Contracts | Other income
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain (Loss) Recognized In Income	(383)	6,007
Interest Rate Contracts | Other expense, net
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain (Loss) Recognized in AOCI (Effective Portion)	0	0
Gain (Loss) Reclassified from AOCI into Income (Effective Portion)	9	(94)
Gain (Loss) Recognized In Income (Excluded from Effectiveness)	$ 0	$ 0

INVENTORIES (Detail)

INVENTORIES (Detail) - USD ($) $ in Thousands	Sep. 25, 2016	Jun. 26, 2016
Inventory Disclosure [Abstract]
Raw materials	$ 549,406	$ 536,844
Work-in-process	139,120	151,406
Finished goods	243,055	283,661
Total inventories	$ 931,581	$ 971,911	[1]
[1]	Derived from audited financial statements

GOODWILL AND INTANGIBLE ASSET49

GOODWILL AND INTANGIBLE ASSETS - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended
	Sep. 25, 2016	Sep. 27, 2015	Jun. 26, 2016	[1]
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	$ 1,385,838		$ 1,386,276
Tax deductible goodwill	61,100
Intangible asset amortization expense	$ 38,700	$ 39,000
[1]	Derived from audited financial statements

GOODWILL AND INTANGIBLE ASSET50

GOODWILL AND INTANGIBLE ASSETS - Schedule of Intangible Assets (Detail) - USD ($) $ in Thousands	Sep. 25, 2016	Jun. 26, 2016
Finite-Lived Intangible Assets [Line Items]
Gross	$ 1,331,121	$ 1,330,872
Accumulated Amortization	(804,528)	(765,951)
Net	526,593	564,921
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Gross	615,193	615,272
Accumulated Amortization	(317,130)	(300,711)
Net	298,063	314,561
Existing technology
Finite-Lived Intangible Assets [Line Items]
Gross	643,261	643,433
Accumulated Amortization	(422,518)	(401,036)
Net	220,743	242,397
Patents
Finite-Lived Intangible Assets [Line Items]
Gross	36,553	36,053
Accumulated Amortization	(29,335)	(28,701)
Net	7,218	7,352
Other intangible assets
Finite-Lived Intangible Assets [Line Items]
Gross	36,114	36,114
Accumulated Amortization	(35,545)	(35,503)
Net	$ 569	$ 611

GOODWILL AND INTANGIBLE ASSET51

GOODWILL AND INTANGIBLE ASSETS - Estimated Future Amortization Expense of Intangible Assets (Detail) - USD ($) $ in Thousands	Sep. 25, 2016	Jun. 26, 2016
Fiscal Year
2017 (remaining 9 months)	$ 116,002
2,018	153,337
2,019	115,263
2,020	50,194
2,021	47,792
Thereafter	44,005
Net	$ 526,593	$ 564,921

ACCRUED EXPENSES AND OTHER CU52

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Detail) - USD ($) $ in Thousands	Sep. 25, 2016	Jun. 26, 2016
Payables and Accruals [Abstract]
Accrued compensation	$ 357,134	$ 331,528
Warranty reserves	103,226	100,321
Income and other taxes payable	68,057	86,723
Dividend payable	48,397	48,052
Other	188,841	206,286
Accrued expenses and other current liabilities	$ 765,655	$ 772,910	[1]
[1]	Derived from audited financial statements

LONG-TERM DEBT AND OTHER BORR53

LONG-TERM DEBT AND OTHER BORROWINGS - Schedule of Outstanding Debt (Details) - USD ($) $ in Thousands	Sep. 25, 2016	Jun. 26, 2016	Jun. 07, 2016	Mar. 12, 2015	Jun. 30, 2012	May 31, 2011
Debt Instrument [Line Items]
Amount	$ 4,549,830	$ 4,549,849
Unamortized discount	(226,811)	(232,727)
Fair value adjustment - interest rate contracts	7,592	8,552
Unamortized bond issuance costs	(6,781)	(7,213)
Total debt outstanding, at carrying value	4,323,830	4,318,461
Current portion of long-term debt	945,836	940,537
Long-term debt	3,377,994	3,377,924
Total debt outstanding, at carrying value	4,323,830	4,318,461
Fixed-rate 1.25% Convertible Notes Due May 15, 2018 (2018 Notes)
Debt Instrument [Line Items]
Senior notes interest rate (percentage)						1.25%
Fixed-rate 2.625% Convertible Notes Due May 15, 2041 (2041 Notes)
Debt Instrument [Line Items]
Senior notes interest rate (percentage)					2.625%
Convertible debt | Fixed-rate 1.25% Convertible Notes Due May 15, 2018 (2018 Notes)
Debt Instrument [Line Items]
Amount	$ 449,947	$ 449,954
Effective Interest Rate	5.27%	5.27%
Senior notes interest rate (percentage)	1.25%
Convertible debt | Fixed-rate 2.625% Convertible Notes Due May 15, 2041 (2041 Notes)
Debt Instrument [Line Items]
Amount	$ 699,883	$ 699,895
Effective Interest Rate	4.28%	4.28%
Senior notes interest rate (percentage)	2.625%
Senior notes | Fixed-rate 2.75% Senior Notes Due March 15, 2020 (2020 Notes)
Debt Instrument [Line Items]
Amount	$ 500,000	$ 500,000
Effective Interest Rate	2.88%	2.88%
Senior notes interest rate (percentage)	2.75%			2.75%
Senior notes | Fixed-rate 2.80% Senior Notes Due June 15, 2021 (2021 Notes)
Debt Instrument [Line Items]
Amount	$ 800,000		$ 800,000
Effective Interest Rate	2.95%	2.95%
Senior notes interest rate (percentage)	2.80%		2.80%
Senior notes | Fixed-rate 3.45% Senior Notes Due June 15, 2023 (2023 Notes)
Debt Instrument [Line Items]
Amount	$ 600,000		$ 600,000
Effective Interest Rate	3.60%	3.60%
Senior notes interest rate (percentage)	3.45%		3.45%
Senior notes | Fixed-rate 3.80% Senior Notes Due March 15, 2025 (2025 Notes)
Debt Instrument [Line Items]
Amount	$ 500,000	$ 500,000
Effective Interest Rate	3.87%	3.87%
Senior notes interest rate (percentage)	3.80%			3.80%
Senior notes | Fixed-rate 3.90% Senior Notes Due June 15, 2026 (2026 Notes)
Debt Instrument [Line Items]
Amount	$ 1,000,000		$ 1,000,000
Effective Interest Rate	4.01%	4.01%
Senior notes interest rate (percentage)	3.90%		3.90%

LONG-TERM DEBT AND OTHER BORR54

LONG-TERM DEBT AND OTHER BORROWINGS - Schedule of Outstanding Debt Footnotes (Details) $ in Thousands	3 Months Ended
	Sep. 25, 2016d	Jun. 26, 2016USD ($)
ASU 2015-3 | Prepaid expense and other assets
Debt Instrument [Line Items]
Bond issuance costs		$ (1,760)
ASU 2015-3 | Other assets
Debt Instrument [Line Items]
Bond issuance costs		(5,450)
ASU 2015-3 | Current portion of convertible notes and capital leases
Debt Instrument [Line Items]
Bond issuance costs		1,760
ASU 2015-3 | Senior notes, convertible notes, and capital leases, less current portion
Debt Instrument [Line Items]
Bond issuance costs		$ 5,450
Convertible debt
Debt Instrument [Line Items]
Stock price percentage of conversion price	130.00%
Number of days on which common stock sale price was greater than or equal to 130% of conversion price, in a period of 30 consecutive trading days ending on the last trading day of the preceding the quarter | d	20
Number of consecutive trading days period required	30 days

LONG-TERM DEBT AND OTHER BORR55

LONG-TERM DEBT AND OTHER BORROWINGS - Convertible Senior Notes (Details) - USD ($)	1 Months Ended
	Jun. 30, 2012	May 31, 2011
Fixed-rate 1.25% Convertible Notes Due May 15, 2018 (2018 Notes)
Debt Instrument [Line Items]
Principal amount		$ 450,000,000
Senior notes interest rate (percentage)		1.25%
Fixed-rate 2.625% Convertible Notes Due May 15, 2041 (2041 Notes)
Debt Instrument [Line Items]
Principal amount	$ 700,000,000
Senior notes interest rate (percentage)	2.625%
Fixed-rate 2.625% Convertible Notes Due May 15, 2041 (2041 Notes) | Maximum
Debt Instrument [Line Items]
Maximum amount of contingent interest rate (percentage)	0.60%

LONG-TERM DEBT AND OTHER BORR56

LONG-TERM DEBT AND OTHER BORROWINGS - Components of Convertible Senior Notes (Detail) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended	12 Months Ended
	Sep. 25, 2016USD ($)$ / sharesshares	Jun. 26, 2016USD ($)
Fixed-rate 1.25% Convertible Notes Due May 15, 2018 (2018 Notes)
Debt Instrument [Line Items]
Remaining amortization period (years)	1 year 7 months 20 days	1 year 10 months 20 days
Fair Value of Notes (Level 2)	$ 701,242
Conversion rate (shares of common stock per $1,000 principal amount of notes)	0.0163893
Conversion price (per share of common stock) (in dollars per share) | $ / shares	$ 61.02
If-converted value in excess of par value	$ 226,868
Estimated share dilution using average quarterly stock price $90.25 per share (in shares) | shares	2,389
Fixed-rate 1.25% Convertible Notes Due May 15, 2018 (2018 Notes) | Permanent Equity
Debt Instrument [Line Items]
Carrying amount of equity component, net of tax	$ 77,064	$ 72,992
Fixed-rate 1.25% Convertible Notes Due May 15, 2018 (2018 Notes) | Temporary Equity
Debt Instrument [Line Items]
Carrying amount of equity component, net of tax	$ 27,818	$ 31,894
Fixed-rate 2.625% Convertible Notes Due May 15, 2041 (2041 Notes)
Debt Instrument [Line Items]
Remaining amortization period (years)	24 years 7 months 20 days	24 years 10 months 20 days
Fair Value of Notes (Level 2)	$ 1,906,194
Conversion rate (shares of common stock per $1,000 principal amount of notes)	0.0294126
Conversion price (per share of common stock) (in dollars per share) | $ / shares	$ 34
If-converted value in excess of par value	$ 1,189,443
Estimated share dilution using average quarterly stock price $90.25 per share (in shares) | shares	12,830
Fixed-rate 2.625% Convertible Notes Due May 15, 2041 (2041 Notes) | Permanent Equity
Debt Instrument [Line Items]
Carrying amount of equity component, net of tax	$ 153,384	$ 152,397
Fixed-rate 2.625% Convertible Notes Due May 15, 2041 (2041 Notes) | Temporary Equity
Debt Instrument [Line Items]
Carrying amount of equity component, net of tax	$ 174,649	$ 175,658

LONG-TERM DEBT AND OTHER BORR57

LONG-TERM DEBT AND OTHER BORROWINGS - Components of Convertible Notes (Phantom) (Detail)	Sep. 25, 2016USD ($)$ / shares
Fixed-rate 1.25% Convertible Notes Due May 15, 2018 (2018 Notes)
Debt Instrument [Line Items]
Principal amount of convertible debt conversion increments | $	$ 1,000
Average quarterly stock price (in dollars per share) | $ / shares	$ 90.25
Fixed-rate 2.625% Convertible Notes Due May 15, 2041 (2041 Notes)
Debt Instrument [Line Items]
Principal amount of convertible debt conversion increments | $	$ 1,000
Average quarterly stock price (in dollars per share) | $ / shares	$ 90.25

LONG-TERM DEBT AND OTHER BORR58

LONG-TERM DEBT AND OTHER BORROWINGS - Convertible Note Hedges and Warrants (Details) - USD ($) shares in Millions	3 Months Ended
	Sep. 25, 2016	May 31, 2011
Debt Instrument [Line Items]
Stock issued (in shares)	1.1
Fixed-rate 1.25% Convertible Notes Due May 15, 2018 (2018 Notes)
Debt Instrument [Line Items]
Principal amount		$ 450,000,000

LONG-TERM DEBT AND OTHER BORR59

LONG-TERM DEBT AND OTHER BORROWINGS - Warrants and Convertible Note Hedge Arrangements (Detail) - $ / shares shares in Thousands	3 Months Ended
	Sep. 25, 2016	Sep. 27, 2015
Class of Warrant or Right [Line Items]
Estimated share dilution using average quarterly stock price $90.25 per share (in shares)	2,048	358
0.50% Notes due 2016 | Warrants
Class of Warrant or Right [Line Items]
Underlying shares	3,098
Estimated share dilution using average quarterly stock price $90.25 per share (in shares)	694
Average quarterly stock price (in dollars per share)	$ 90.25
Exercise price (in dollars per share)	69.0739
0.50% Notes due 2016 | Convertible Note Hedge
Class of Warrant or Right [Line Items]
Exercise price (in dollars per share)	$ 0
Number of shares available from counterparties	0
Fixed-rate 1.25% Convertible Notes Due May 15, 2018 (2018 Notes)
Class of Warrant or Right [Line Items]
Average quarterly stock price (in dollars per share)	$ 90.25
Fixed-rate 1.25% Convertible Notes Due May 15, 2018 (2018 Notes) | Warrants
Class of Warrant or Right [Line Items]
Underlying shares	7,375
Estimated share dilution using average quarterly stock price $90.25 per share (in shares)	1,354
Average quarterly stock price (in dollars per share)	$ 90.25
Exercise price (in dollars per share)	73.6827
Fixed-rate 1.25% Convertible Notes Due May 15, 2018 (2018 Notes) | Convertible Note Hedge
Class of Warrant or Right [Line Items]
Exercise price (in dollars per share)	$ 61.0154
Number of shares available from counterparties	7,374

LONG-TERM DEBT AND OTHER BORR60

LONG-TERM DEBT AND OTHER BORROWINGS - Senior Notes (Details) - USD ($)	Mar. 12, 2015	Dec. 25, 2016	Sep. 25, 2016	Oct. 05, 2016	Jun. 26, 2016	Jun. 07, 2016
Debt Instrument [Line Items]
Amount			$ 4,549,830,000		$ 4,549,849,000
Senior notes
Debt Instrument [Line Items]
Percentage of principal amount of debt redeemed (percentage)	100.00%
Senior notes | Fixed-rate 2.75% Senior Notes Due March 15, 2020 (2020 Notes)
Debt Instrument [Line Items]
Principal amount	$ 500,000,000
Senior notes interest rate (percentage)	2.75%		2.75%
Amount			$ 500,000,000		500,000,000
Senior notes | Fixed-rate 3.80% Senior Notes Due March 15, 2025 (2025 Notes)
Debt Instrument [Line Items]
Principal amount	$ 500,000,000
Senior notes interest rate (percentage)	3.80%		3.80%
Debt instrument, redemption price (percentage)	101.00%
Amount			$ 500,000,000		$ 500,000,000
Senior notes | Fixed-rate 2.80% Senior Notes Due June 15, 2021 (2021 Notes)
Debt Instrument [Line Items]
Senior notes interest rate (percentage)			2.80%			2.80%
Percentage of principal amount of debt redeemed (percentage)			100.00%
Debt instrument, redemption price (percentage)			101.00%
Amount			$ 800,000,000			$ 800,000,000
Senior notes | Fixed-rate 3.45% Senior Notes Due June 15, 2023 (2023 Notes)
Debt Instrument [Line Items]
Senior notes interest rate (percentage)			3.45%			3.45%
Amount			$ 600,000,000			$ 600,000,000
Senior notes | Fixed-rate 3.90% Senior Notes Due June 15, 2026 (2026 Notes)
Debt Instrument [Line Items]
Senior notes interest rate (percentage)			3.90%			3.90%
Amount			$ 1,000,000,000			$ 1,000,000,000
Senior notes | Notes due in 2023 and 2026 | Subsequent event
Debt Instrument [Line Items]
Accrued and unpaid interest				$ 21,000,000
Loan issuance cost		$ 2,500,000

LONG-TERM DEBT AND OTHER BORR61

LONG-TERM DEBT AND OTHER BORROWINGS - Schedule of Additional Senior Notes Information (Details) $ in Thousands	3 Months Ended
	Sep. 25, 2016USD ($)
2020 Notes
Debt Instrument [Line Items]
Remaining amortization period (years)	3 years 5 months 12 days
2021 Notes
Debt Instrument [Line Items]
Remaining amortization period (years)	4 years 8 months 20 days
2025 Notes
Debt Instrument [Line Items]
Remaining amortization period (years)	8 years 5 months 12 days
Fair Value of Derivative Instruments (Level 2) | 2020 Notes
Debt Instrument [Line Items]
Fair Value of Notes (Level 2)	$ 501,375
Fair Value of Derivative Instruments (Level 2) | 2021 Notes
Debt Instrument [Line Items]
Fair Value of Notes (Level 2)	821,224
Fair Value of Derivative Instruments (Level 2) | 2023 Notes
Debt Instrument [Line Items]
Fair Value of Notes (Level 2)	615,000
Fair Value of Derivative Instruments (Level 2) | 2025 Notes
Debt Instrument [Line Items]
Fair Value of Notes (Level 2)	514,100
Fair Value of Derivative Instruments (Level 2) | 2026 Notes
Debt Instrument [Line Items]
Fair Value of Notes (Level 2)	$ 1,046,340

LONG-TERM DEBT AND OTHER BORR62

LONG-TERM DEBT AND OTHER BORROWINGS - Schedule of Recognized Interest Cost Relating to Both Contractual Interest Coupon and Amortization of Discount on Liability Component of Notes (Detail) - USD ($) $ in Thousands	3 Months Ended
	Sep. 25, 2016	Sep. 27, 2015
Debt Disclosure [Abstract]
Contractual interest coupon	$ 34,712	$ 14,451
Amortization of interest discount	5,914	9,122
Amortization of issuance costs	918	652
Effect of interest rate contracts, net	(1,058)	94
Total interest cost recognized	$ 40,486	$ 24,319

LONG-TERM DEBT AND OTHER BORR63

LONG-TERM DEBT AND OTHER BORROWINGS - Term Loan Agreement (Details) - Unsecured Debt - USD ($)	3 Months Ended
	Dec. 25, 2016	May 13, 2016
Forecast | Subsequent event
Debt Instrument [Line Items]
Loan issuance cost	$ 3,700,000
Unsecured Term Loan Agreement Total
Debt Instrument [Line Items]
Principal amount		$ 1,530,000,000
Unsecured Term Loan Agreement, 3 Year Tranche Due 2018
Debt Instrument [Line Items]
Principal amount		1,005,000,000
Unsecured Term Loan Agreement, 5 Year Tranche Due 2020
Debt Instrument [Line Items]
Principal amount		$ 525,000,000

LONG-TERM DEBT AND OTHER BORR64

LONG-TERM DEBT AND OTHER BORROWINGS - Revolving Credit Facility (Details) - Revolving credit facility - USD ($)	Apr. 26, 2016	Mar. 12, 2014
Extinguishment of Debt [Line Items]
Revolving unsecured credit facility	$ 750,000,000	$ 300,000,000
Additional increase in the facility	250,000,000
Revolving unsecured credit facility maximum borrowing capacity	$ 1,000,000,000
Federal Funds Rate
Extinguishment of Debt [Line Items]
Variable interest spread (percentage)	0.50%
One-month LIBOR
Extinguishment of Debt [Line Items]
Variable interest spread (percentage)	1.00%
One-month LIBOR | Minimum
Extinguishment of Debt [Line Items]
Variable interest spread (percentage)	0.00%
One-month LIBOR | Maximum
Extinguishment of Debt [Line Items]
Variable interest spread (percentage)	0.50%
LIBOR | Minimum
Extinguishment of Debt [Line Items]
Variable interest spread (percentage)	0.90%
LIBOR | Maximum
Extinguishment of Debt [Line Items]
Variable interest spread (percentage)	1.50%

COMMITMENTS AND CONTINGENCIES -

COMMITMENTS AND CONTINGENCIES - Additional Information (Detail) - USD ($)	3 Months Ended
	Sep. 25, 2016	Jun. 26, 2016	[1]
Loss Contingencies [Line Items]
Restricted cash and investments	$ 255,640,000	$ 250,421,000
Letters of Credit
Loss Contingencies [Line Items]
Guarantee obligation maximum exposure	13,000,000
Operating Leases
Loss Contingencies [Line Items]
Operating Lease residual value of guarantee, maximum	$ 220,400,000
Maximum percentage of aggregate investment value guaranteed (percentage)	100.00%
Guarantee obligation maximum exposure	$ 250,027,000
Operating Lease Cash Collateral
Loss Contingencies [Line Items]
Restricted cash and investments	$ 250,000,000
[1]	Derived from audited financial statements

COMMITMENTS AND CONTINGENCIES66

COMMITMENTS AND CONTINGENCIES - Schedule of Changes in Product Warranty Reserves (Detail) - USD ($) $ in Thousands	3 Months Ended
	Sep. 25, 2016	Sep. 27, 2015
Changes in Product Warranty Reserve
Balance at beginning of period	$ 100,321	$ 93,209
Warranties issued during the period	34,855	34,203
Settlements made during the period	(32,228)	(28,458)
Changes in liability for pre-existing warranties	278	14
Balance at end of period	$ 103,226	$ 98,968

STOCK REPURCHASE PROGRAM (Detai

STOCK REPURCHASE PROGRAM (Detail) - USD ($)	3 Months Ended
	Sep. 25, 2016	Apr. 29, 2014
Equity [Abstract]
Authorized repurchase of Company common stock		$ 850,000,000
Remaining available for purchase (shares)	$ 229,100,000
Net shares of settlements to cover tax withholding obligations (in shares)	20,475
Amount paid for shares under net share settlements	$ 1,900,000

ACCUMULATED OTHER COMPREHENSI68

ACCUMULATED OTHER COMPREHENSIVE LOSS - Components of Accumulated Other Comprehensive Loss (Detail) - USD ($) $ in Thousands		3 Months Ended
		Sep. 25, 2016	Sep. 27, 2015
Change in Accumulated Other Comprehensive Loss
Beginning balance	[1]	$ 5,894,517
Other comprehensive income (loss) before reclassifications		(719)
Losses reclassified from accumulated other comprehensive income (loss) to net income		13,052
Other comprehensive loss, net of tax		12,333	$ (5,162)
Ending balance		6,184,883
Accumulated foreign currency translation adjustment
Change in Accumulated Other Comprehensive Loss
Beginning balance		(39,528)
Other comprehensive income (loss) before reclassifications		4,302
Losses reclassified from accumulated other comprehensive income (loss) to net income		199
Other comprehensive loss, net of tax		4,501
Ending balance		(35,027)
Accumulated unrealized holding gain (loss) on cash flow hedges
Change in Accumulated Other Comprehensive Loss
Beginning balance		(15,623)
Other comprehensive income (loss) before reclassifications		(2,421)
Losses reclassified from accumulated other comprehensive income (loss) to net income		11,950
Other comprehensive loss, net of tax		9,529
Ending balance		(6,094)
Accumulated unrealized holding gain (loss) on available- for-sale investments
Change in Accumulated Other Comprehensive Loss
Beginning balance		4,896
Other comprehensive income (loss) before reclassifications		(2,723)
Losses reclassified from accumulated other comprehensive income (loss) to net income		903
Other comprehensive loss, net of tax		(1,820)
Ending balance		3,076
Accumulated unrealized components of defined benefit plans
Change in Accumulated Other Comprehensive Loss
Beginning balance		(19,078)
Other comprehensive income (loss) before reclassifications		123
Losses reclassified from accumulated other comprehensive income (loss) to net income		0
Other comprehensive loss, net of tax		123
Ending balance		(18,955)
Total
Change in Accumulated Other Comprehensive Loss
Beginning balance		(69,333)
Ending balance		$ (57,000)
[1]	Derived from audited financial statements

ACCUMULATED OTHER COMPREHENSI69

ACCUMULATED OTHER COMPREHENSIVE LOSS - Components of Accumulated Other Comprehensive Loss (Foot Notes) (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 25, 2016	Sep. 27, 2015
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Revenue	$ (1,632,419)	$ (1,600,043)
Cost of goods sold	(916,222)	(877,680)
Selling, general and administrative	165,010	152,726
Other income and expense	(23,154)	$ (27,121)
Accumulated unrealized holding gain (loss) on cash flow hedges | Reclassified from accumulated other comprehensive income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Revenue	12,094
Cost of goods sold	147
Selling, general and administrative	9
Other income and expense	$ 6

(Detail)

(Detail) $ in Millions	3 Months Ended
	Sep. 25, 2016USD ($)
Selling, general, and administrative
Business Acquisition [Line Items]
Acquisition related costs	$ 10